A Genome-wide Association Study of Copy Number Variation in Hematological Parameters in the Korean Population.
('A', 'A', 'DT', 'B-NP', 'O')
('Genome-wide', 'Genome-wide', 'JJ', 'I-NP', 'O')
('Association', 'Association', 'NNP', 'I-NP', 'O')
('Study', 'Study', 'NNP', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('Copy', 'Copy', 'NNP', 'B-NP', 'O')
('Number', 'Number', 'NNP', 'I-NP', 'O')
('Variation', 'Variation', 'NNP', 'I-NP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('Hematological', 'Hematological', 'NNP', 'B-NP', 'O')
('Parameters', 'Parameters', 'NNP', 'I-NP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('Korean', 'Korean', 'NNP', 'I-NP', 'O')
('Population.', 'Population.', 'NNP', 'I-NP', 'O')
Abnormal hematological values are associated with various disorders including cancer and cardiovascular, metabolic, infectious, and immune diseases.
('Abnormal', 'Abnormal', 'JJ', 'B-NP', 'O')
('hematological', 'hematological', 'JJ', 'I-NP', 'O')
('values', 'value', 'NNS', 'I-NP', 'O')
('are', 'be', 'VBP', 'B-VP', 'O')
('associated', 'associate', 'VBN', 'I-VP', 'O')
('with', 'with', 'IN', 'B-PP', 'O')
('various', 'various', 'JJ', 'B-NP', 'O')
('disorders', 'disorder', 'NNS', 'I-NP', 'O')
('including', 'include', 'VBG', 'B-PP', 'O')
('cancer', 'cancer', 'NN', 'B-NP', 'O')
('and', 'and', 'CC', 'I-NP', 'O')
('cardiovascular,', 'cardiovascular,', 'NN', 'I-NP', 'O')
('metabolic,', 'metabolic,', 'NN', 'I-NP', 'O')
('infectious,', 'infectious,', 'NN', 'I-NP', 'O')
('and', 'and', 'CC', 'O', 'O')
('immune', 'immune', 'JJ', 'B-NP', 'O')
('diseases.', 'diseases.', 'NNS', 'I-NP', 'O')
We report the copy number variations (CNVs) in clinically relevant hematological parameters, including hemoglobin level, red and white blood cell counts, platelet counts, and red blood cell (RBC) volume.
('We', 'We', 'PRP', 'B-NP', 'O')
('report', 'report', 'VBP', 'B-VP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('copy', 'copy', 'NN', 'I-NP', 'O')
('number', 'number', 'NN', 'I-NP', 'O')
('variations', 'variation', 'NNS', 'I-NP', 'O')
('(CNVs)', '(CNVs)', 'NN', 'I-NP', 'B-protein')
('in', 'in', 'IN', 'B-PP', 'O')
('clinically', 'clinically', 'RB', 'B-NP', 'O')
('relevant', 'relevant', 'JJ', 'I-NP', 'O')
('hematological', 'hematological', 'JJ', 'I-NP', 'O')
('parameters,', 'parameters,', 'NN', 'I-NP', 'O')
('including', 'include', 'VBG', 'B-PP', 'O')
('hemoglobin', 'hemoglobin', 'NN', 'B-NP', 'B-protein')
('level,', 'level,', 'NN', 'I-NP', 'O')
('red', 'red', 'JJ', 'I-NP', 'O')
('and', 'and', 'CC', 'I-NP', 'O')
('white', 'white', 'JJ', 'I-NP', 'O')
('blood', 'blood', 'NN', 'I-NP', 'O')
('cell', 'cell', 'NN', 'I-NP', 'O')
('counts,', 'counts,', 'NN', 'I-NP', 'O')
('platelet', 'platelet', 'NN', 'I-NP', 'O')
('counts,', 'counts,', 'NN', 'I-NP', 'O')
('and', 'and', 'CC', 'O', 'O')
('red', 'red', 'JJ', 'B-NP', 'O')
('blood', 'blood', 'NN', 'I-NP', 'O')
('cell', 'cell', 'NN', 'I-NP', 'O')
('(RBC)', '(RBC)', 'NN', 'I-NP', 'O')
('volume.', 'volume.', 'NN', 'I-NP', 'O')
We describe CNVs in several loci associated with these hematological parameters in 8,842 samples from Korean populationbased studies.
('We', 'We', 'PRP', 'B-NP', 'O')
('describe', 'describe', 'VBP', 'B-VP', 'O')
('CNVs', 'CNV', 'NNS', 'B-NP', 'B-protein')
('in', 'in', 'IN', 'B-PP', 'O')
('several', 'several', 'JJ', 'B-NP', 'O')
('loci', 'locus', 'NNS', 'I-NP', 'O')
('associated', 'associate', 'VBN', 'B-VP', 'O')
('with', 'with', 'IN', 'B-PP', 'O')
('these', 'these', 'DT', 'B-NP', 'O')
('hematological', 'hematological', 'JJ', 'I-NP', 'O')
('parameters', 'parameter', 'NNS', 'I-NP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('8,842', '8,842', 'CD', 'B-NP', 'O')
('samples', 'sample', 'NNS', 'I-NP', 'O')
('from', 'from', 'IN', 'B-PP', 'O')
('Korean', 'Korean', 'JJ', 'B-NP', 'O')
('populationbased', 'populationbased', 'JJ', 'I-NP', 'O')
('studies.', 'studies.', 'NNS', 'I-NP', 'O')
The data that we evaluated included four RBC parameters, one platelet parameter, and one associated with total white blood cell (WBC) count, exceeding the genome-wide significance.
('The', 'The', 'DT', 'B-NP', 'O')
('data', 'datum', 'NNS', 'I-NP', 'O')
('that', 'that', 'IN', 'B-NP', 'O')
('we', 'we', 'PRP', 'B-NP', 'O')
('evaluated', 'evaluate', 'VBD', 'B-VP', 'O')
('included', 'include', 'VBN', 'I-VP', 'O')
('four', 'four', 'CD', 'B-NP', 'O')
('RBC', 'RBC', 'NNS', 'I-NP', 'B-cell_type')
('parameters,', 'parameters,', 'VBD', 'B-VP', 'O')
('one', 'one', 'CD', 'B-NP', 'O')
('platelet', 'platelet', 'NN', 'I-NP', 'O')
('parameter,', 'parameter,', 'NN', 'I-NP', 'O')
('and', 'and', 'CC', 'O', 'O')
('one', 'one', 'CD', 'B-NP', 'O')
('associated', 'associate', 'VBN', 'B-VP', 'O')
('with', 'with', 'IN', 'B-PP', 'O')
('total', 'total', 'JJ', 'B-NP', 'O')
('white', 'white', 'JJ', 'I-NP', 'O')
('blood', 'blood', 'NN', 'I-NP', 'O')
('cell', 'cell', 'NN', 'I-NP', 'O')
('(WBC)', '(WBC)', 'NN', 'I-NP', 'O')
('count,', 'count,', 'NN', 'I-NP', 'O')
('exceeding', 'exceed', 'VBG', 'B-VP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('genome-wide', 'genome-wide', 'JJ', 'I-NP', 'O')
('significance.', 'significance.', 'NN', 'I-NP', 'O')
We show that CNVs in hematological parameters are associated with some loci, different from previously associated loci reported in single nucleotide polymorphism (SNP) association studies.
('We', 'We', 'PRP', 'B-NP', 'O')
('show', 'show', 'VBP', 'B-VP', 'O')
('that', 'that', 'IN', 'B-SBAR', 'O')
('CNVs', 'CNV', 'NNS', 'B-NP', 'B-protein')
('in', 'in', 'IN', 'B-PP', 'O')
('hematological', 'hematological', 'JJ', 'B-NP', 'O')
('parameters', 'parameter', 'NNS', 'I-NP', 'O')
('are', 'be', 'VBP', 'B-VP', 'O')
('associated', 'associate', 'VBN', 'I-VP', 'O')
('with', 'with', 'IN', 'B-PP', 'O')
('some', 'some', 'DT', 'B-NP', 'O')
('loci,', 'loci,', 'NN', 'I-NP', 'O')
('different', 'different', 'JJ', 'B-ADJP', 'O')
('from', 'from', 'IN', 'B-PP', 'O')
('previously', 'previously', 'RB', 'B-NP', 'O')
('associated', 'associate', 'VBN', 'I-NP', 'O')
('loci', 'locus', 'NNS', 'I-NP', 'O')
('reported', 'report', 'VBN', 'B-VP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('single', 'single', 'JJ', 'B-NP', 'O')
('nucleotide', 'nucleotide', 'NN', 'I-NP', 'O')
('polymorphism', 'polymorphism', 'NN', 'I-NP', 'O')
('(SNP)', '(SNP)', 'NN', 'I-NP', 'O')
('association', 'association', 'NN', 'I-NP', 'O')
('studies.', 'studies.', 'NN', 'I-NP', 'O')
The hematopoietic system has various functions including oxygen transport, immunity, blood wall surveillance, homeostasis, and wound curing.
('The', 'The', 'DT', 'B-NP', 'O')
('hematopoietic', 'hematopoietic', 'JJ', 'I-NP', 'O')
('system', 'system', 'NN', 'I-NP', 'O')
('has', 'have', 'VBZ', 'B-VP', 'O')
('various', 'various', 'JJ', 'B-NP', 'O')
('functions', 'function', 'NNS', 'I-NP', 'O')
('including', 'include', 'VBG', 'B-PP', 'O')
('oxygen', 'oxygen', 'NN', 'B-NP', 'O')
('transport,', 'transport,', 'NN', 'I-NP', 'O')
('immunity,', 'immunity,', 'NN', 'I-NP', 'O')
('blood', 'blood', 'NN', 'I-NP', 'O')
('wall', 'wall', 'NN', 'I-NP', 'O')
('surveillance,', 'surveillance,', 'NN', 'I-NP', 'O')
('homeostasis,', 'homeostasis,', 'NN', 'I-NP', 'O')
('and', 'and', 'CC', 'O', 'O')
('wound', 'wound', 'NN', 'B-NP', 'O')
('curing.', 'curing.', 'NN', 'I-NP', 'O')
Hematological parameters include not only the number of white blood cells (WBC) and red blood cells (RBC), but also the number of platelets.
('Hematological', 'Hematological', 'JJ', 'B-NP', 'O')
('parameters', 'parameter', 'NNS', 'I-NP', 'O')
('include', 'include', 'VBP', 'B-VP', 'O')
('not', 'not', 'RB', 'B-CONJP', 'O')
('only', 'only', 'RB', 'I-CONJP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('number', 'number', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('white', 'white', 'JJ', 'B-NP', 'B-cell_type')
('blood', 'blood', 'NN', 'I-NP', 'I-cell_type')
('cells', 'cell', 'NNS', 'I-NP', 'I-cell_type')
('(WBC)', '(WBC)', 'NN', 'I-NP', 'B-protein')
('and', 'and', 'CC', 'O', 'O')
('red', 'red', 'JJ', 'B-NP', 'O')
('blood', 'blood', 'NN', 'I-NP', 'O')
('cells', 'cell', 'NNS', 'I-NP', 'O')
('(RBC),', '(RBC),', 'NN', 'I-NP', 'B-protein')
('but', 'but', 'CC', 'B-CONJP', 'O')
('also', 'also', 'RB', 'I-CONJP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('number', 'number', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('platelets.', 'platelets.', 'NN', 'B-NP', 'O')
The hemoglobin (Hb), the hematocrit (Hct), and the mean corpuscular hemoglobin concentration (MCHC) were also evaluated.
('The', 'The', 'DT', 'B-NP', 'O')
('hemoglobin', 'hemoglobin', 'NN', 'I-NP', 'B-protein')
('(Hb),', '(Hb),', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('hematocrit', 'hematocrit', 'NN', 'I-NP', 'O')
('(Hct),', '(Hct),', 'NN', 'I-NP', 'B-protein')
('and', 'and', 'CC', 'O', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('mean', 'mean', 'JJ', 'I-NP', 'O')
('corpuscular', 'corpuscular', 'JJ', 'I-NP', 'O')
('hemoglobin', 'hemoglobin', 'NN', 'I-NP', 'B-protein')
('concentration', 'concentration', 'NN', 'I-NP', 'O')
('(MCHC)', '(MCHC)', 'NN', 'I-NP', 'O')
('were', 'be', 'VBD', 'B-VP', 'O')
('also', 'also', 'RB', 'I-VP', 'O')
('evaluated.', 'evaluated.', 'VB', 'I-VP', 'O')
All of these parameters are heritable, vary among individuals and are used as an index for clinical treatment (Ferreira et al., 2009).
('All', 'All', 'DT', 'B-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('these', 'these', 'DT', 'B-NP', 'O')
('parameters', 'parameter', 'NNS', 'I-NP', 'O')
('are', 'be', 'VBP', 'B-VP', 'O')
('heritable,', 'heritable,', 'PRP', 'B-NP', 'O')
('vary', 'vary', 'VBP', 'B-VP', 'O')
('among', 'among', 'IN', 'B-PP', 'O')
('individuals', 'individual', 'NNS', 'B-NP', 'O')
('and', 'and', 'CC', 'O', 'O')
('are', 'be', 'VBP', 'B-VP', 'O')
('used', 'use', 'VBN', 'I-VP', 'O')
('as', 'as', 'IN', 'B-PP', 'O')
('an', 'an', 'DT', 'B-NP', 'O')
('index', 'index', 'NN', 'I-NP', 'O')
('for', 'for', 'IN', 'B-PP', 'O')
('clinical', 'clinical', 'JJ', 'B-NP', 'O')
('treatment', 'treatment', 'NN', 'I-NP', 'O')
('(Ferreira', '(Ferreira', 'NNP', 'I-NP', 'O')
('et', 'et', 'NNP', 'I-NP', 'O')
('al.,', 'al.,', 'IN', 'B-PP', 'O')
('2009).', '2009).', 'CD', 'B-NP', 'O')
Abnormal values of hemoglobin concentration are the main indicator of common genetic diseases such as cancer, infection, and immune disease.
('Abnormal', 'Abnormal', 'JJ', 'B-NP', 'O')
('values', 'value', 'NNS', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('hemoglobin', 'hemoglobin', 'NN', 'B-NP', 'B-protein')
('concentration', 'concentration', 'NN', 'I-NP', 'O')
('are', 'be', 'VBP', 'B-VP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('main', 'main', 'JJ', 'I-NP', 'O')
('indicator', 'indicator', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('common', 'common', 'JJ', 'B-NP', 'O')
('genetic', 'genetic', 'JJ', 'I-NP', 'O')
('diseases', 'disease', 'NNS', 'I-NP', 'O')
('such', 'such', 'JJ', 'B-PP', 'O')
('as', 'as', 'IN', 'I-PP', 'O')
('cancer,', 'cancer,', 'NN', 'B-NP', 'O')
('infection,', 'infection,', 'NN', 'I-NP', 'O')
('and', 'and', 'CC', 'O', 'O')
('immune', 'immune', 'JJ', 'B-NP', 'O')
('disease.', 'disease.', 'NN', 'I-NP', 'O')
The RBCs are in charge of blood transport to tissues.
('The', 'The', 'DT', 'B-NP', 'O')
('RBCs', 'RBC', 'NNS', 'I-NP', 'B-cell_type')
('are', 'be', 'VBP', 'B-VP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('charge', 'charge', 'NN', 'B-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('blood', 'blood', 'NN', 'B-NP', 'O')
('transport', 'transport', 'NN', 'I-NP', 'O')
('to', 'to', 'TO', 'B-VP', 'O')
('tissues.', 'tissues.', 'VB', 'I-VP', 'O')
The MCHC value is an index of anemia, and Hct, the proportion of blood volume that is occupied by RBCs, is the index that defines anemia.
('The', 'The', 'DT', 'B-NP', 'O')
('MCHC', 'MCHC', 'NN', 'I-NP', 'O')
('value', 'value', 'NN', 'I-NP', 'O')
('is', 'be', 'VBZ', 'B-VP', 'O')
('an', 'an', 'DT', 'B-NP', 'O')
('index', 'index', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('anemia,', 'anemia,', 'NN', 'B-NP', 'O')
('and', 'and', 'CC', 'I-NP', 'O')
('Hct,', 'Hct,', 'NN', 'I-NP', 'B-protein')
('the', 'the', 'DT', 'B-NP', 'O')
('proportion', 'proportion', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('blood', 'blood', 'NN', 'B-NP', 'O')
('volume', 'volume', 'NN', 'I-NP', 'O')
('that', 'that', 'WDT', 'B-NP', 'O')
('is', 'be', 'VBZ', 'B-VP', 'O')
('occupied', 'occupy', 'VBN', 'I-VP', 'O')
('by', 'by', 'IN', 'B-PP', 'O')
('RBCs,', 'RBCs,', 'NN', 'B-NP', 'B-protein')
('is', 'be', 'VBZ', 'B-VP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('index', 'index', 'NN', 'I-NP', 'O')
('that', 'that', 'WDT', 'B-NP', 'O')
('defines', 'define', 'VBZ', 'B-VP', 'O')
('anemia.', 'anemia.', 'RB', 'B-ADVP', 'O')
An increased number of WBCs is reported to be a risk factor for coronary artery disease (CAD), myocardial infarction (MI), and leukemia (Soranzo et al., 2009).
('An', 'An', 'DT', 'B-NP', 'O')
('increased', 'increase', 'VBN', 'I-NP', 'O')
('number', 'number', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('WBCs', 'WBC', 'NNS', 'B-NP', 'B-protein')
('is', 'be', 'VBZ', 'B-VP', 'O')
('reported', 'report', 'VBN', 'I-VP', 'O')
('to', 'to', 'TO', 'I-VP', 'O')
('be', 'be', 'VB', 'I-VP', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('risk', 'risk', 'NN', 'I-NP', 'O')
('factor', 'factor', 'NN', 'I-NP', 'O')
('for', 'for', 'IN', 'B-PP', 'O')
('coronary', 'coronary', 'JJ', 'B-NP', 'O')
('artery', 'artery', 'NN', 'I-NP', 'O')
('disease', 'disease', 'NN', 'I-NP', 'O')
('(CAD),', '(CAD),', 'NN', 'I-NP', 'O')
('myocardial', 'myocardial', 'JJ', 'I-NP', 'O')
('infarction', 'infarction', 'NN', 'I-NP', 'O')
('(MI),', '(MI),', 'NN', 'I-NP', 'O')
('and', 'and', 'CC', 'O', 'O')
('leukemia', 'leukemia', 'NN', 'B-NP', 'O')
('(Soranzo', '(Soranzo', 'NNP', 'I-NP', 'O')
('et', 'et', 'NNP', 'I-NP', 'O')
('al.,', 'al.,', 'IN', 'B-PP', 'O')
('2009).', '2009).', 'CD', 'B-NP', 'O')
Malfunctions in RBC production such as anemia or erythrocytosis are related to hypertension, cardiovascular diseases, asthma, and atherosclerosis, the heritability is known to be 40~90% (Ganesh et al., 2009).
('Malfunctions', 'Malfunction', 'NNS', 'B-NP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('RBC', 'RBC', 'NN', 'B-NP', 'B-protein')
('production', 'production', 'NN', 'I-NP', 'O')
('such', 'such', 'JJ', 'B-PP', 'O')
('as', 'as', 'IN', 'I-PP', 'O')
('anemia', 'anemia', 'NN', 'B-NP', 'O')
('or', 'or', 'CC', 'I-NP', 'O')
('erythrocytosis', 'erythrocytosis', 'NN', 'I-NP', 'O')
('are', 'be', 'VBP', 'B-VP', 'O')
('related', 'relate', 'VBN', 'I-VP', 'O')
('to', 'to', 'TO', 'I-VP', 'O')
('hypertension,', 'hypertension,', 'VB', 'I-VP', 'O')
('cardiovascular', 'cardiovascular', 'JJ', 'B-NP', 'O')
('diseases,', 'diseases,', 'NN', 'I-NP', 'O')
('asthma,', 'asthma,', 'NN', 'I-NP', 'O')
('and', 'and', 'CC', 'B-PP', 'O')
('atherosclerosis,', 'atherosclerosis,', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('heritability', 'heritability', 'NN', 'I-NP', 'O')
('is', 'be', 'VBZ', 'B-VP', 'O')
('known', 'know', 'VBN', 'I-VP', 'O')
('to', 'to', 'TO', 'I-VP', 'O')
('be', 'be', 'VB', 'I-VP', 'O')
('40~90%', '40~90%', 'JJ', 'B-NP', 'O')
('(Ganesh', '(Ganesh', 'NNP', 'I-NP', 'O')
('et', 'et', 'NNP', 'I-NP', 'O')
('al.,', 'al.,', 'IN', 'B-PP', 'O')
('2009).', '2009).', 'CD', 'B-NP', 'O')
Platelets have important roles in the clotting system, and increased platelet count is related to cardiovascular diseases and cancer (Soranzo et al., 2009).
('Platelets', 'Platelet', 'NNS', 'B-NP', 'B-cell_type')
('have', 'have', 'VBP', 'B-VP', 'O')
('important', 'important', 'JJ', 'B-NP', 'O')
('roles', 'role', 'NNS', 'I-NP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('clotting', 'clotting', 'NN', 'I-NP', 'O')
('system,', 'system,', 'NN', 'I-NP', 'O')
('and', 'and', 'CC', 'O', 'O')
('increased', 'increase', 'VBD', 'B-VP', 'O')
('platelet', 'platelet', 'NN', 'B-NP', 'O')
('count', 'count', 'NN', 'I-NP', 'O')
('is', 'be', 'VBZ', 'B-VP', 'O')
('related', 'related', 'JJ', 'B-ADJP', 'O')
('to', 'to', 'TO', 'B-PP', 'O')
('cardiovascular', 'cardiovascular', 'JJ', 'B-NP', 'O')
('diseases', 'disease', 'NNS', 'I-NP', 'O')
('and', 'and', 'CC', 'O', 'O')
('cancer', 'cancer', 'NN', 'B-NP', 'O')
('(Soranzo', '(Soranzo', 'NNP', 'I-NP', 'O')
('et', 'et', 'NNP', 'I-NP', 'O')
('al.,', 'al.,', 'IN', 'B-PP', 'O')
('2009).', '2009).', 'CD', 'B-NP', 'O')
A recent genomewide association study (GWAS) of single nucleotide polymorphism (SNP) has shown a significant association among hematological traits (Ganesh et al., 2009; Kamatani et al., 2010; Soranzo et al., 2009).
('A', 'A', 'DT', 'B-NP', 'O')
('recent', 'recent', 'JJ', 'I-NP', 'O')
('genomewide', 'genomewide', 'JJ', 'I-NP', 'O')
('association', 'association', 'NN', 'I-NP', 'O')
('study', 'study', 'NN', 'I-NP', 'O')
('(GWAS)', '(GWAS)', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('single', 'single', 'JJ', 'B-NP', 'O')
('nucleotide', 'nucleotide', 'NN', 'I-NP', 'O')
('polymorphism', 'polymorphism', 'NN', 'I-NP', 'O')
('(SNP)', '(SNP)', 'NN', 'I-NP', 'O')
('has', 'have', 'VBZ', 'B-VP', 'O')
('shown', 'show', 'VBN', 'I-VP', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('significant', 'significant', 'JJ', 'I-NP', 'O')
('association', 'association', 'NN', 'I-NP', 'O')
('among', 'among', 'IN', 'B-PP', 'O')
('hematological', 'hematological', 'JJ', 'B-NP', 'B-cell_type')
('traits', 'trait', 'NNS', 'I-NP', 'I-cell_type')
('(Ganesh', '(Ganesh', 'NNP', 'B-NP', 'I-cell_type')
('et', 'et', 'FW', 'I-NP', 'I-cell_type')
('al.,', 'al.,', 'FW', 'I-NP', 'I-cell_type')
('2009;', '2009;', ':', 'O', 'I-cell_type')
('Kamatani', 'Kamatani', 'NNP', 'B-NP', 'O')
('et', 'et', 'FW', 'I-NP', 'O')
('al.,', 'al.,', 'FW', 'I-NP', 'O')
('2010;', '2010;', ':', 'O', 'O')
('Soranzo', 'Soranzo', 'NNP', 'B-NP', 'O')
('et', 'et', 'NNP', 'I-NP', 'O')
('al.,', 'al.,', 'IN', 'B-PP', 'O')
('2009).', '2009).', 'CD', 'B-NP', 'O')
The copy number variations (CNV) representing structural variants were recently reported to be related to disease susceptibility such as HIV infection, autoimmune disease, asthma, and nervous disease.
('The', 'The', 'DT', 'B-NP', 'O')
('copy', 'copy', 'NN', 'I-NP', 'O')
('number', 'number', 'NN', 'I-NP', 'O')
('variations', 'variation', 'NNS', 'I-NP', 'O')
('(CNV)', '(CNV)', 'NN', 'I-NP', 'B-protein')
('representing', 'represent', 'VBG', 'B-VP', 'O')
('structural', 'structural', 'JJ', 'B-NP', 'O')
('variants', 'variant', 'NNS', 'I-NP', 'O')
('were', 'be', 'VBD', 'B-VP', 'O')
('recently', 'recently', 'RB', 'I-VP', 'O')
('reported', 'report', 'VBN', 'I-VP', 'O')
('to', 'to', 'TO', 'I-VP', 'O')
('be', 'be', 'VB', 'I-VP', 'O')
('related', 'relate', 'VBN', 'I-VP', 'O')
('to', 'to', 'TO', 'B-PP', 'O')
('disease', 'disease', 'NN', 'B-NP', 'O')
('susceptibility', 'susceptibility', 'NN', 'I-NP', 'O')
('such', 'such', 'JJ', 'B-PP', 'O')
('as', 'as', 'IN', 'I-PP', 'O')
('HIV', 'HIV', 'NN', 'B-NP', 'O')
('infection,', 'infection,', 'NN', 'I-NP', 'O')
('autoimmune', 'autoimmune', 'JJ', 'I-NP', 'O')
('disease,', 'disease,', 'NN', 'I-NP', 'O')
('asthma,', 'asthma,', 'NN', 'I-NP', 'O')
('and', 'and', 'CC', 'O', 'O')
('nervous', 'nervous', 'JJ', 'B-NP', 'O')
('disease.', 'disease.', 'NN', 'I-NP', 'O')
However, the association of CNV to hematological traits has not been reported.
('However,', 'However,', 'WRB', 'B-ADVP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('association', 'association', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('CNV', 'CNV', 'NN', 'B-NP', 'B-protein')
('to', 'to', 'TO', 'B-PP', 'O')
('hematological', 'hematological', 'JJ', 'B-NP', 'B-cell_type')
('traits', 'trait', 'NNS', 'I-NP', 'I-cell_type')
('has', 'have', 'VBZ', 'B-VP', 'O')
('not', 'not', 'RB', 'I-VP', 'O')
('been', 'be', 'VBN', 'I-VP', 'O')
('reported.', 'reported.', 'VBN', 'I-VP', 'O')
The purpose of this study was to determine a genetic relationship between SNPs and CNVs of hematological traits in the general Korean population.
('The', 'The', 'DT', 'B-NP', 'O')
('purpose', 'purpose', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('this', 'this', 'DT', 'B-NP', 'O')
('study', 'study', 'NN', 'I-NP', 'O')
('was', 'be', 'VBD', 'B-VP', 'O')
('to', 'to', 'TO', 'B-VP', 'O')
('determine', 'determine', 'VB', 'I-VP', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('genetic', 'genetic', 'JJ', 'I-NP', 'O')
('relationship', 'relationship', 'NN', 'I-NP', 'O')
('between', 'between', 'IN', 'B-PP', 'O')
('SNPs', 'SNP', 'NNS', 'B-NP', 'B-protein')
('and', 'and', 'CC', 'I-NP', 'O')
('CNVs', 'CNV', 'NNS', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('hematological', 'hematological', 'JJ', 'B-NP', 'B-cell_type')
('traits', 'trait', 'NNS', 'I-NP', 'I-cell_type')
('in', 'in', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('general', 'general', 'JJ', 'I-NP', 'O')
('Korean', 'Korean', 'JJ', 'I-NP', 'O')
('population.', 'population.', 'NN', 'I-NP', 'O')
We carried out GWAS of CNV for the chosen traits and identified several loci associated with these traits.
('We', 'We', 'PRP', 'B-NP', 'O')
('carried', 'carry', 'VBD', 'B-VP', 'O')
('out', 'out', 'RP', 'B-PRT', 'O')
('GWAS', 'GWAS', 'NN', 'B-NP', 'B-protein')
('of', 'of', 'IN', 'B-PP', 'O')
('CNV', 'CNV', 'NN', 'B-NP', 'B-protein')
('for', 'for', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('chosen', 'choose', 'VBN', 'I-NP', 'O')
('traits', 'trait', 'NNS', 'I-NP', 'O')
('and', 'and', 'CC', 'O', 'O')
('identified', 'identify', 'VBD', 'B-VP', 'O')
('several', 'several', 'JJ', 'B-NP', 'O')
('loci', 'locus', 'NNS', 'I-NP', 'O')
('associated', 'associate', 'VBN', 'B-VP', 'O')
('with', 'with', 'IN', 'B-PP', 'O')
('these', 'these', 'DT', 'B-NP', 'O')
('traits.', 'traits.', 'NN', 'I-NP', 'O')
The loci identified in our study are different from than those reported in a previous GWAS of SNP.
('The', 'The', 'DT', 'B-NP', 'O')
('loci', 'locus', 'NNS', 'I-NP', 'O')
('identified', 'identify', 'VBN', 'B-VP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('our', 'our', 'PRP$', 'B-NP', 'O')
('study', 'study', 'NN', 'I-NP', 'O')
('are', 'be', 'VBP', 'B-VP', 'O')
('different', 'different', 'JJ', 'B-ADJP', 'O')
('from', 'from', 'IN', 'B-PP', 'O')
('than', 'than', 'IN', 'B-PP', 'O')
('those', 'those', 'DT', 'B-NP', 'O')
('reported', 'report', 'VBN', 'B-VP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('previous', 'previous', 'JJ', 'I-NP', 'O')
('GWAS', 'GWAS', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('SNP.', 'SNP.', 'NNP', 'B-NP', 'O')
We collected data from 10,004 individuals in two populations from rural Ansung and urban Ansan cohorts as   part of the Korean Genome Epidemiology Study (KoGES).
('We', 'We', 'PRP', 'B-NP', 'O')
('collected', 'collect', 'VBD', 'B-VP', 'O')
('data', 'datum', 'NNS', 'B-NP', 'O')
('from', 'from', 'IN', 'B-PP', 'O')
('10,004', '10,004', 'CD', 'B-NP', 'O')
('individuals', 'individual', 'NNS', 'I-NP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('two', 'two', 'CD', 'B-NP', 'O')
('populations', 'population', 'NNS', 'I-NP', 'O')
('from', 'from', 'IN', 'B-PP', 'O')
('rural', 'rural', 'JJ', 'B-NP', 'O')
('Ansung', 'Ansung', 'NN', 'I-NP', 'O')
('and', 'and', 'CC', 'O', 'O')
('urban', 'urban', 'JJ', 'B-NP', 'O')
('Ansan', 'Ansan', 'NNP', 'I-NP', 'O')
('cohorts', 'cohort', 'NNS', 'I-NP', 'O')
('as', 'as', 'IN', 'B-PP', 'O')
('part', 'part', 'NN', 'B-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('Korean', 'Korean', 'NNP', 'I-NP', 'B-DNA')
('Genome', 'Genome', 'NNP', 'I-NP', 'I-DNA')
('Epidemiology', 'Epidemiology', 'NNP', 'I-NP', 'O')
('Study', 'Study', 'NNP', 'I-NP', 'O')
('(KoGES).', '(KoGES).', 'NNP', 'I-NP', 'O')
The initial samples included 5,018 and 5,020 respective participants aged 40 to 69.
('The', 'The', 'DT', 'B-NP', 'O')
('initial', 'initial', 'JJ', 'I-NP', 'O')
('samples', 'sample', 'NNS', 'I-NP', 'O')
('included', 'include', 'VBD', 'B-VP', 'O')
('5,018', '5,018', 'CD', 'B-NP', 'O')
('and', 'and', 'CC', 'I-NP', 'O')
('5,020', '5,020', 'CD', 'I-NP', 'O')
('respective', 'respective', 'JJ', 'I-NP', 'O')
('participants', 'participant', 'NNS', 'I-NP', 'O')
('aged', 'age', 'VBN', 'B-ADJP', 'O')
('40', '40', 'CD', 'B-NP', 'O')
('to', 'to', 'TO', 'B-PP', 'O')
('69.', '69.', 'CD', 'B-NP', 'O')
Detailed information was shown in a previous study (Cho et al., 2009).
('Detailed', 'Detailed', 'JJ', 'B-NP', 'O')
('information', 'information', 'NN', 'I-NP', 'O')
('was', 'be', 'VBD', 'B-VP', 'O')
('shown', 'show', 'VBN', 'I-VP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('previous', 'previous', 'JJ', 'I-NP', 'O')
('study', 'study', 'NN', 'I-NP', 'O')
('(Cho', '(Cho', 'NNP', 'I-NP', 'O')
('et', 'et', 'NNP', 'I-NP', 'O')
('al.,', 'al.,', 'IN', 'B-PP', 'O')
('2009).', '2009).', 'CD', 'B-NP', 'O')
The characteristics of the hematological traits are summarized in Fig.
('The', 'The', 'DT', 'B-NP', 'O')
('characteristics', 'characteristic', 'NNS', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('hematological', 'hematological', 'JJ', 'I-NP', 'O')
('traits', 'trait', 'NNS', 'I-NP', 'O')
('are', 'be', 'VBP', 'B-VP', 'O')
('summarized', 'summarize', 'VBN', 'I-VP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('Fig.', 'Fig.', 'NNP', 'B-NP', 'O')
1 and Table 1.
('1', '1', 'CD', 'B-NP', 'O')
('and', 'and', 'CC', 'I-NP', 'O')
('Table', 'Table', 'JJ', 'I-NP', 'O')
('1.', '1.', 'CD', 'I-NP', 'O')
The majority of genomic DNA genotyped on the Affymetrix Genome-Wide Human SNP array 5.0 was isolated from peripheral blood drawn from cohort participants.
('The', 'The', 'DT', 'B-NP', 'O')
('majority', 'majority', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('genomic', 'genomic', 'JJ', 'B-NP', 'B-DNA')
('DNA', 'DNA', 'NN', 'I-NP', 'I-DNA')
('genotyped', 'genotype', 'VBN', 'B-VP', 'O')
('on', 'on', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('Affymetrix', 'Affymetrix', 'NNP', 'I-NP', 'O')
('Genome-Wide', 'Genome-Wide', 'NNP', 'I-NP', 'O')
('Human', 'Human', 'JJ', 'I-NP', 'O')
('SNP', 'SNP', 'NN', 'I-NP', 'O')
('array', 'array', 'NN', 'I-NP', 'O')
('5.0', '5.0', 'CD', 'I-NP', 'O')
('was', 'be', 'VBD', 'B-VP', 'O')
('isolated', 'isolate', 'VBN', 'I-VP', 'O')
('from', 'from', 'IN', 'B-PP', 'O')
('peripheral', 'peripheral', 'JJ', 'B-NP', 'O')
('blood', 'blood', 'NN', 'I-NP', 'O')
('drawn', 'draw', 'VBN', 'B-VP', 'O')
('from', 'from', 'IN', 'B-PP', 'O')
('cohort', 'cohort', 'JJ', 'B-NP', 'O')
('participants.', 'participants.', 'NNS', 'I-NP', 'O')
Samples were genotyped using 500 ng of genomic DNA and the Bayesian Robust Linear Modeling using the Mahalanobis Distance (BRLMM) Genotyping Algorithm for genotype determination of 500,568 SNPs.
('Samples', 'Sample', 'NNS', 'B-NP', 'O')
('were', 'be', 'VBD', 'B-VP', 'O')
('genotyped', 'genotype', 'VBN', 'I-VP', 'O')
('using', 'use', 'VBG', 'B-VP', 'O')
('500', '500', 'CD', 'B-NP', 'O')
('ng', 'ng', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('genomic', 'genomic', 'JJ', 'B-NP', 'B-DNA')
('DNA', 'DNA', 'NN', 'I-NP', 'I-DNA')
('and', 'and', 'CC', 'O', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('Bayesian', 'Bayesian', 'NNP', 'I-NP', 'O')
('Robust', 'Robust', 'NNP', 'I-NP', 'O')
('Linear', 'Linear', 'NNP', 'I-NP', 'O')
('Modeling', 'Modeling', 'NNP', 'I-NP', 'O')
('using', 'use', 'VBG', 'B-VP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('Mahalanobis', 'Mahalanobis', 'NNP', 'I-NP', 'O')
('Distance', 'Distance', 'NNP', 'I-NP', 'O')
('(BRLMM)', '(BRLMM)', 'NNP', 'I-NP', 'O')
('Genotyping', 'Genotyping', 'NNP', 'I-NP', 'O')
('Algorithm', 'Algorithm', 'NNP', 'I-NP', 'O')
('for', 'for', 'IN', 'B-PP', 'O')
('genotype', 'genotype', 'NN', 'B-NP', 'O')
('determination', 'determination', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('500,568', '500,568', 'CD', 'B-NP', 'O')
('SNPs.', 'SNPs.', 'NN', 'I-NP', 'O')
Samples were excluded due to high missing genotype call rate, high heterozygosity, and gender inconsistencies.
('Samples', 'Sample', 'NNS', 'B-NP', 'O')
('were', 'be', 'VBD', 'B-VP', 'O')
('excluded', 'exclude', 'VBN', 'I-VP', 'O')
('due', 'due', 'JJ', 'B-ADJP', 'O')
('to', 'to', 'TO', 'B-PP', 'O')
('high', 'high', 'JJ', 'B-NP', 'O')
('missing', 'missing', 'JJ', 'I-NP', 'O')
('genotype', 'genotype', 'NN', 'I-NP', 'O')
('call', 'call', 'NN', 'I-NP', 'O')
('rate,', 'rate,', 'NN', 'I-NP', 'O')
('high', 'high', 'JJ', 'I-NP', 'O')
('heterozygosity,', 'heterozygosity,', 'NN', 'I-NP', 'O')
('and', 'and', 'CC', 'I-NP', 'O')
('gender', 'gender', 'NN', 'I-NP', 'O')
('inconsistencies.', 'inconsistencies.', 'NNS', 'I-NP', 'O')
Also, any samples that had been obtained from individuals who had developed any kind of cancer or high pairwise identitybystate (IBS) were also excluded, leaving a total of 8,842 individuals.
('Also,', 'Also,', 'IN', 'B-PP', 'O')
('any', 'any', 'DT', 'B-NP', 'O')
('samples', 'sample', 'NNS', 'I-NP', 'O')
('that', 'that', 'WDT', 'B-NP', 'O')
('had', 'have', 'VBD', 'B-VP', 'O')
('been', 'be', 'VBN', 'I-VP', 'O')
('obtained', 'obtain', 'VBN', 'I-VP', 'O')
('from', 'from', 'IN', 'B-PP', 'O')
('individuals', 'individual', 'NNS', 'B-NP', 'O')
('who', 'who', 'WP', 'B-NP', 'O')
('had', 'have', 'VBD', 'B-VP', 'O')
('developed', 'develop', 'VBN', 'I-VP', 'O')
('any', 'any', 'DT', 'B-NP', 'O')
('kind', 'kind', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('cancer', 'cancer', 'NN', 'B-NP', 'O')
('or', 'or', 'CC', 'O', 'O')
('high', 'high', 'JJ', 'B-NP', 'O')
('pairwise', 'pairwise', 'JJ', 'I-NP', 'O')
('identitybystate', 'identitybystate', 'NN', 'I-NP', 'O')
('(IBS)', '(IBS)', 'NN', 'I-NP', 'O')
('were', 'be', 'VBD', 'B-VP', 'O')
('also', 'also', 'RB', 'B-ADVP', 'O')
('excluded,', 'excluded,', 'NN', 'B-NP', 'O')
('leaving', 'leave', 'VBG', 'B-VP', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('total', 'total', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('8,842', '8,842', 'CD', 'B-NP', 'O')
('individuals.', 'individuals.', 'NNS', 'I-NP', 'O')
We used PennCNV to perform CNV calling which simultaneously incorporates the log R ratio and B allele frequency based on a hidden Markov model (HMM) framework.
('We', 'We', 'PRP', 'B-NP', 'O')
('used', 'use', 'VBD', 'B-VP', 'O')
('PennCNV', 'PennCNV', 'NNP', 'B-NP', 'O')
('to', 'to', 'TO', 'B-VP', 'O')
('perform', 'perform', 'VB', 'I-VP', 'O')
('CNV', 'CNV', 'NN', 'B-NP', 'O')
('calling', 'calling', 'NN', 'I-NP', 'O')
('which', 'which', 'WDT', 'B-NP', 'O')
('simultaneously', 'simultaneously', 'RB', 'B-ADVP', 'O')
('incorporates', 'incorporate', 'VBZ', 'B-VP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('log', 'log', 'NN', 'I-NP', 'O')
('R', 'R', 'NN', 'I-NP', 'O')
('ratio', 'ratio', 'NN', 'I-NP', 'O')
('and', 'and', 'CC', 'I-NP', 'O')
('B', 'B', 'NN', 'I-NP', 'O')
('allele', 'allele', 'NN', 'I-NP', 'O')
('frequency', 'frequency', 'NN', 'I-NP', 'O')
('based', 'base', 'VBN', 'B-VP', 'O')
('on', 'on', 'IN', 'B-PP', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('hidden', 'hidden', 'JJ', 'I-NP', 'O')
('Markov', 'Markov', 'NNP', 'I-NP', 'O')
('model', 'model', 'NN', 'I-NP', 'O')
('(HMM)', '(HMM)', 'NNP', 'I-NP', 'O')
('framework.', 'framework.', 'NN', 'I-NP', 'O')
We adopted the detail state definition for more precise modeling of CNV events (Colella et al., 2007).
('We', 'We', 'PRP', 'B-NP', 'O')
('adopted', 'adopt', 'VBD', 'B-VP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('detail', 'detail', 'JJ', 'I-NP', 'O')
('state', 'state', 'NN', 'I-NP', 'O')
('definition', 'definition', 'NN', 'I-NP', 'O')
('for', 'for', 'IN', 'B-PP', 'O')
('more', 'more', 'RBR', 'B-NP', 'O')
('precise', 'precise', 'JJ', 'I-NP', 'O')
('modeling', 'modeling', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('CNV', 'CNV', 'NN', 'B-NP', 'O')
('events', 'event', 'NNS', 'I-NP', 'O')
('(Colella', '(Colella', 'NNP', 'I-NP', 'O')
('et', 'et', 'NN', 'I-NP', 'O')
('al.,', 'al.,', 'IN', 'B-PP', 'O')
('2007).', '2007).', 'CD', 'B-NP', 'O')
The procedure for CNV calling is described in a previous report (Wang et al., 2007).
('The', 'The', 'DT', 'B-NP', 'O')
('procedure', 'procedure', 'NN', 'I-NP', 'O')
('for', 'for', 'IN', 'B-PP', 'O')
('CNV', 'CNV', 'NN', 'B-NP', 'O')
('calling', 'calling', 'NN', 'I-NP', 'O')
('is', 'be', 'VBZ', 'B-VP', 'O')
('described', 'describe', 'VBN', 'I-VP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('previous', 'previous', 'JJ', 'I-NP', 'O')
('report', 'report', 'NN', 'I-NP', 'O')
('(Wang', '(Wang', 'NNP', 'I-NP', 'O')
('et', 'et', 'NNP', 'I-NP', 'O')
('al.,', 'al.,', 'IN', 'B-PP', 'O')
('2007).', '2007).', 'CD', 'B-NP', 'O')
Most association analyses were conducted using PLINK (version 2.6) and R programs (version 2.9).
('Most', 'Most', 'JJS', 'B-NP', 'O')
('association', 'association', 'NN', 'I-NP', 'O')
('analyses', 'analysis', 'NNS', 'I-NP', 'O')
('were', 'be', 'VBD', 'B-VP', 'O')
('conducted', 'conduct', 'VBN', 'I-VP', 'O')
('using', 'use', 'VBG', 'B-VP', 'O')
('PLINK', 'PLINK', 'NN', 'B-NP', 'B-protein')
('(version', '(version', 'NN', 'I-NP', 'I-protein')
('2.6)', '2.6)', 'CD', 'B-NP', 'I-protein')
('and', 'and', 'CC', 'I-NP', 'O')
('R', 'R', 'NN', 'I-NP', 'O')
('programs', 'program', 'NNS', 'I-NP', 'O')
('(version', '(version', 'NN', 'B-NP', 'O')
('2.9).', '2.9).', 'CD', 'I-NP', 'O')
For each hematological trait, we set control where the value was   　　　　　　　　　　　　　within normal value and case where the values were lower than normal (Table 2).
('For', 'For', 'IN', 'B-PP', 'O')
('each', 'each', 'DT', 'B-NP', 'O')
('hematological', 'hematological', 'JJ', 'I-NP', 'O')
('trait,', 'trait,', 'NN', 'I-NP', 'O')
('we', 'we', 'PRP', 'B-NP', 'O')
('set', 'set', 'VBP', 'B-VP', 'O')
('control', 'control', 'NN', 'B-NP', 'O')
('where', 'where', 'WRB', 'B-ADVP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('value', 'value', 'NN', 'I-NP', 'O')
('was', 'be', 'VBD', 'B-VP', 'O')
('\u3000\u3000\u3000\u3000\u3000\u3000\u3000\u3000\u3000\u3000\u3000\u3000\u3000within', '\u3000\u3000\u3000\u3000\u3000\u3000\u3000\u3000\u3000\u3000\u3000\u3000\u3000within', 'JJ', 'B-NP', 'O')
('normal', 'normal', 'JJ', 'I-NP', 'O')
('value', 'value', 'NN', 'I-NP', 'O')
('and', 'and', 'CC', 'I-NP', 'O')
('case', 'case', 'NN', 'I-NP', 'O')
('where', 'where', 'WRB', 'B-ADVP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('values', 'value', 'NNS', 'I-NP', 'O')
('were', 'be', 'VBD', 'B-VP', 'O')
('lower', 'low', 'JJR', 'B-ADJP', 'O')
('than', 'than', 'IN', 'B-PP', 'O')
('normal', 'normal', 'JJ', 'B-NP', 'O')
('(Table', '(Table', 'JJ', 'I-NP', 'O')
('2).', '2).', 'NN', 'I-NP', 'O')
The case-control status of hematological traits was tested for association using Fisher’s exact test.
('The', 'The', 'DT', 'B-NP', 'O')
('case-control', 'case-control', 'JJ', 'I-NP', 'O')
('status', 'status', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('hematological', 'hematological', 'JJ', 'B-NP', 'B-cell_type')
('traits', 'trait', 'NNS', 'I-NP', 'I-cell_type')
('was', 'be', 'VBD', 'B-VP', 'O')
('tested', 'test', 'VBN', 'I-VP', 'O')
('for', 'for', 'IN', 'B-PP', 'O')
('association', 'association', 'NN', 'B-NP', 'O')
('using', 'use', 'VBG', 'B-VP', 'O')
('Fisher’s', 'Fisher’', 'NNS', 'B-NP', 'O')
('exact', 'exact', 'VBP', 'B-VP', 'O')
('test.', 'test.', 'NN', 'B-NP', 'O')
The GWAS results with Manhattan plots are shown in Fig.
('The', 'The', 'DT', 'B-NP', 'O')
('GWAS', 'GWAS', 'NN', 'I-NP', 'O')
('results', 'result', 'NNS', 'I-NP', 'O')
('with', 'with', 'IN', 'B-PP', 'O')
('Manhattan', 'Manhattan', 'NNP', 'B-NP', 'O')
('plots', 'plot', 'NNS', 'I-NP', 'O')
('are', 'be', 'VBP', 'B-VP', 'O')
('shown', 'show', 'VBN', 'I-VP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('Fig.', 'Fig.', 'NNP', 'B-NP', 'O')
2 and Supplementary Fig.
('2', '2', 'CD', 'B-NP', 'O')
('and', 'and', 'CC', 'O', 'O')
('Supplementary', 'Supplementary', 'NNP', 'B-NP', 'O')
('Fig.', 'Fig.', 'NNP', 'I-NP', 'O')
1-6.
('1-6.', '1-6.', 'LS', 'B-LST', 'O')
The average number of CNVs per genome was 41.2 kb, larger than those of the CNVs previously reported using lower resolution platforms.
('The', 'The', 'DT', 'B-NP', 'O')
('average', 'average', 'JJ', 'I-NP', 'O')
('number', 'number', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('CNVs', 'CNV', 'NNS', 'B-NP', 'B-DNA')
('per', 'per', 'IN', 'B-PP', 'I-DNA')
('genome', 'genome', 'NN', 'B-NP', 'I-DNA')
('was', 'be', 'VBD', 'B-VP', 'O')
('41.2', '41.2', 'CD', 'B-NP', 'O')
('kb,', 'kb,', 'NN', 'I-NP', 'O')
('larger', 'large', 'JJR', 'B-ADJP', 'O')
('than', 'than', 'IN', 'B-PP', 'O')
('those', 'those', 'DT', 'B-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('CNVs', 'CNV', 'NNS', 'I-NP', 'B-protein')
('previously', 'previously', 'RB', 'B-VP', 'O')
('reported', 'report', 'VBN', 'I-VP', 'O')
('using', 'use', 'VBG', 'B-VP', 'O')
('lower', 'low', 'JJR', 'B-NP', 'O')
('resolution', 'resolution', 'NN', 'I-NP', 'O')
('platforms.', 'platforms.', 'NN', 'I-NP', 'O')
However, these results are similar to those of a previous report of healthy, unrelated Korean people provided by the Korea National Institute of Health (KNIH).
('However,', 'However,', 'WRB', 'B-ADVP', 'O')
('these', 'these', 'DT', 'B-NP', 'O')
('results', 'result', 'NNS', 'I-NP', 'O')
('are', 'be', 'VBP', 'B-VP', 'O')
('similar', 'similar', 'JJ', 'B-ADJP', 'O')
('to', 'to', 'TO', 'B-PP', 'O')
('those', 'those', 'DT', 'B-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('previous', 'previous', 'JJ', 'I-NP', 'O')
('report', 'report', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('healthy,', 'healthy,', 'NN', 'B-NP', 'O')
('unrelated', 'unrelated', 'JJ', 'I-NP', 'O')
('Korean', 'Korean', 'JJ', 'I-NP', 'O')
('people', 'people', 'NNS', 'I-NP', 'O')
('provided', 'provide', 'VBN', 'B-VP', 'O')
('by', 'by', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('Korea', 'Korea', 'NNP', 'I-NP', 'O')
('National', 'National', 'NNP', 'I-NP', 'O')
('Institute', 'Institute', 'NNP', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('Health', 'Health', 'NNP', 'B-NP', 'O')
('(KNIH).', '(KNIH).', 'NNP', 'I-NP', 'O')
The median copy number gain was 54.4 kb (range 0.028788.5 kb), and that of copy number loss was 47.6 kb (range 0.0320075.4 kb).
('The', 'The', 'DT', 'B-NP', 'O')
('median', 'median', 'JJ', 'I-NP', 'O')
('copy', 'copy', 'NN', 'I-NP', 'O')
('number', 'number', 'NN', 'I-NP', 'O')
('gain', 'gain', 'NN', 'I-NP', 'O')
('was', 'be', 'VBD', 'B-VP', 'O')
('54.4', '54.4', 'CD', 'B-NP', 'O')
('kb', 'kb', 'NN', 'I-NP', 'O')
('(range', '(range', 'NN', 'I-NP', 'O')
('0.028788.5', '0.028788.5', 'CD', 'I-NP', 'O')
('kb),', 'kb),', 'NN', 'I-NP', 'O')
('and', 'and', 'CC', 'O', 'O')
('that', 'that', 'DT', 'B-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('copy', 'copy', 'NN', 'B-NP', 'O')
('number', 'number', 'NN', 'I-NP', 'O')
('loss', 'loss', 'NN', 'I-NP', 'O')
('was', 'be', 'VBD', 'B-VP', 'O')
('47.6', '47.6', 'CD', 'B-NP', 'O')
('kb', 'kb', 'NN', 'I-NP', 'O')
('(range', '(range', 'NN', 'I-NP', 'O')
('0.0320075.4', '0.0320075.4', 'CD', 'B-NP', 'O')
('kb).', 'kb).', 'NN', 'I-NP', 'O')
Copy number losses were 2.8 times more frequent and smaller than were copy number gains.
('Copy', 'Copy', 'NN', 'B-NP', 'O')
('number', 'number', 'NN', 'I-NP', 'O')
('losses', 'loss', 'NNS', 'I-NP', 'O')
('were', 'be', 'VBD', 'B-VP', 'O')
('2.8', '2.8', 'CD', 'B-NP', 'O')
('times', 'time', 'NNS', 'I-NP', 'O')
('more', 'more', 'RBR', 'B-ADJP', 'O')
('frequent', 'frequent', 'JJ', 'I-ADJP', 'O')
('and', 'and', 'CC', 'O', 'O')
('smaller', 'small', 'JJR', 'B-ADJP', 'O')
('than', 'than', 'IN', 'B-SBAR', 'O')
('were', 'be', 'VBD', 'B-VP', 'O')
('copy', 'copy', 'NN', 'B-NP', 'O')
('number', 'number', 'NN', 'I-NP', 'O')
('gains.', 'gains.', 'NN', 'I-NP', 'O')
Our range of CNV size was wider and had less frequent ratio losses to gains compared to those in previous reports (Yim et al., 2010).
('Our', 'Our', 'PRP$', 'B-NP', 'O')
('range', 'range', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('CNV', 'CNV', 'NN', 'B-NP', 'O')
('size', 'size', 'NN', 'I-NP', 'O')
('was', 'be', 'VBD', 'B-VP', 'O')
('wider', 'wide', 'JJR', 'B-ADJP', 'O')
('and', 'and', 'CC', 'O', 'O')
('had', 'have', 'VBD', 'B-VP', 'O')
('less', 'less', 'RBR', 'B-NP', 'O')
('frequent', 'frequent', 'JJ', 'I-NP', 'O')
('ratio', 'ratio', 'NN', 'I-NP', 'O')
('losses', 'loss', 'NNS', 'I-NP', 'O')
('to', 'to', 'TO', 'B-PP', 'O')
('gains', 'gain', 'NNS', 'B-NP', 'O')
('compared', 'compare', 'VBN', 'B-VP', 'O')
('to', 'to', 'TO', 'B-PP', 'O')
('those', 'those', 'DT', 'B-NP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('previous', 'previous', 'JJ', 'B-NP', 'O')
('reports', 'report', 'NNS', 'I-NP', 'O')
('(Yim', '(Yim', 'NNP', 'B-NP', 'O')
('et', 'et', 'NN', 'I-NP', 'O')
('al.,', 'al.,', 'IN', 'B-PP', 'O')
('2010).', '2010).', 'CD', 'B-NP', 'O')
GWAS for WBC count revealed few newly associated loci.
('GWAS', 'GWAS', 'NN', 'B-NP', 'B-protein')
('for', 'for', 'IN', 'B-PP', 'O')
('WBC', 'WBC', 'NN', 'B-NP', 'O')
('count', 'count', 'NN', 'I-NP', 'O')
('revealed', 'reveal', 'VBD', 'B-VP', 'O')
('few', 'few', 'JJ', 'B-NP', 'O')
('newly', 'newly', 'RB', 'I-NP', 'O')
('associated', 'associate', 'VBN', 'I-NP', 'O')
('loci.', 'loci.', 'NN', 'I-NP', 'O')
Association of CNVs with WBC was found in loci   on 2q22 (p=5.2×10−7).
('Association', 'Association', 'NN', 'B-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('CNVs', 'CNV', 'NNS', 'B-NP', 'B-protein')
('with', 'with', 'IN', 'B-PP', 'O')
('WBC', 'WBC', 'NN', 'B-NP', 'B-protein')
('was', 'be', 'VBD', 'B-VP', 'O')
('found', 'find', 'VBN', 'I-VP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('loci', 'locus', 'NNS', 'B-NP', 'O')
('on', 'on', 'IN', 'B-PP', 'O')
('2q22', '2q22', 'CD', 'B-NP', 'B-DNA')
('(p=5.2×10−7).', '(p=5.2×10−7).', 'LS', 'O', 'O')
The nearest gene, nebulin (NEB) encodes the giant nebulin protein component of the cytoskeletal matrix that coexists with the myosin and actin filaments within the sarcomeres of skeletal muscle and is expressed in most tissues.
('The', 'The', 'DT', 'B-NP', 'O')
('nearest', 'near', 'JJS', 'I-NP', 'O')
('gene,', 'gene,', 'NN', 'I-NP', 'O')
('nebulin', 'nebulin', 'NN', 'I-NP', 'O')
('(NEB)', '(NEB)', 'NN', 'I-NP', 'O')
('encodes', 'encode', 'VBZ', 'B-VP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('giant', 'giant', 'JJ', 'I-NP', 'O')
('nebulin', 'nebulin', 'NN', 'I-NP', 'O')
('protein', 'protein', 'NN', 'I-NP', 'O')
('component', 'component', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('cytoskeletal', 'cytoskeletal', 'JJ', 'I-NP', 'O')
('matrix', 'matrix', 'NN', 'I-NP', 'O')
('that', 'that', 'WDT', 'B-NP', 'O')
('coexists', 'coexist', 'VBZ', 'B-VP', 'O')
('with', 'with', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('myosin', 'myosin', 'NN', 'I-NP', 'O')
('and', 'and', 'CC', 'I-NP', 'O')
('actin', 'actin', 'NN', 'I-NP', 'B-protein')
('filaments', 'filament', 'NNS', 'I-NP', 'I-protein')
('within', 'within', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('sarcomeres', 'sarcomere', 'NNS', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('skeletal', 'skeletal', 'JJ', 'B-NP', 'O')
('muscle', 'muscle', 'NN', 'I-NP', 'O')
('and', 'and', 'CC', 'O', 'O')
('is', 'be', 'VBZ', 'B-VP', 'O')
('expressed', 'express', 'VBN', 'I-VP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('most', 'most', 'JJS', 'B-NP', 'O')
('tissues.', 'tissues.', 'NN', 'I-NP', 'O')
We performed GWAS for four erythrocyterelated traits, red blood cell (RBC) count, hemoglobin (Hb) concentration, hematocrit (Hct), and mean corpuscular hemoglobin concentration (MCHC).
('We', 'We', 'PRP', 'B-NP', 'O')
('performed', 'perform', 'VBD', 'B-VP', 'O')
('GWAS', 'GWAS', 'NN', 'B-NP', 'B-protein')
('for', 'for', 'IN', 'B-PP', 'O')
('four', 'four', 'CD', 'B-NP', 'O')
('erythrocyterelated', 'erythrocyterelated', 'JJ', 'I-NP', 'O')
('traits,', 'traits,', 'NN', 'I-NP', 'O')
('red', 'red', 'JJ', 'I-NP', 'O')
('blood', 'blood', 'NN', 'I-NP', 'O')
('cell', 'cell', 'NN', 'I-NP', 'O')
('(RBC)', '(RBC)', 'NN', 'I-NP', 'O')
('count,', 'count,', 'NN', 'I-NP', 'O')
('hemoglobin', 'hemoglobin', 'NN', 'I-NP', 'O')
('(Hb)', '(Hb)', 'NN', 'I-NP', 'O')
('concentration,', 'concentration,', 'NN', 'I-NP', 'O')
('hematocrit', 'hematocrit', 'NN', 'I-NP', 'O')
('(Hct),', '(Hct),', 'NN', 'I-NP', 'O')
('and', 'and', 'CC', 'O', 'O')
('mean', 'mean', 'JJ', 'B-NP', 'O')
('corpuscular', 'corpuscular', 'JJ', 'I-NP', 'O')
('hemoglobin', 'hemoglobin', 'NN', 'I-NP', 'B-protein')
('concentration', 'concentration', 'NN', 'I-NP', 'O')
('(MCHC).', '(MCHC).', 'NN', 'I-NP', 'O')
Clustered CNV gains on 8p11.11 (p=1.8×10−10∼5.5×10−8), a nearby centromere of chromosome 8, are associated with RBCs (Supplementary Fig.
('Clustered', 'Cluster', 'VBN', 'B-NP', 'O')
('CNV', 'CNV', 'NN', 'I-NP', 'B-protein')
('gains', 'gain', 'NNS', 'I-NP', 'I-protein')
('on', 'on', 'IN', 'B-PP', 'O')
('8p11.11', '8p11.11', 'CD', 'B-NP', 'O')
('(p=1.8×10−10∼5.5×10−8),', '(p=1.8×10−10∼5.5×10−8),', 'NN', 'I-NP', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('nearby', 'nearby', 'JJ', 'I-NP', 'O')
('centromere', 'centromere', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('chromosome', 'chromosome', 'NN', 'B-NP', 'B-DNA')
('8,', '8,', 'NN', 'I-NP', 'I-DNA')
('are', 'be', 'VBP', 'B-VP', 'O')
('associated', 'associate', 'VBN', 'I-VP', 'O')
('with', 'with', 'IN', 'B-PP', 'O')
('RBCs', 'RBC', 'NNS', 'B-NP', 'B-cell_type')
('(Supplementary', '(Supplementary', 'NNP', 'I-NP', 'O')
('Fig.', 'Fig.', 'NNP', 'I-NP', 'O')
2).
('2).', '2).', 'LS', 'B-LST', 'O')
The nearest gene was a POTE ankyrin domain family, member A (POTEA), the protein of which is known to be expressed in pancreas, ovary, testis and placenta.
('The', 'The', 'DT', 'B-NP', 'O')
('nearest', 'near', 'JJS', 'I-NP', 'B-DNA')
('gene', 'gene', 'NN', 'I-NP', 'I-DNA')
('was', 'be', 'VBD', 'B-VP', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('POTE', 'POTE', 'NN', 'I-NP', 'O')
('ankyrin', 'ankyrin', 'NN', 'I-NP', 'O')
('domain', 'domain', 'NN', 'I-NP', 'O')
('family,', 'family,', 'NN', 'I-NP', 'O')
('member', 'member', 'NN', 'I-NP', 'O')
('A', 'A', 'NN', 'I-NP', 'O')
('(POTEA),', '(POTEA),', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('protein', 'protein', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('which', 'which', 'WDT', 'B-NP', 'O')
('is', 'be', 'VBZ', 'B-VP', 'O')
('known', 'know', 'VBN', 'I-VP', 'O')
('to', 'to', 'TO', 'I-VP', 'O')
('be', 'be', 'VB', 'I-VP', 'O')
('expressed', 'express', 'VBN', 'I-VP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('pancreas,', 'pancreas,', 'NN', 'B-NP', 'O')
('ovary,', 'ovary,', 'NN', 'I-NP', 'O')
('testis', 'testis', 'NN', 'I-NP', 'O')
('and', 'and', 'CC', 'O', 'O')
('placenta.', 'placenta.', 'NN', 'B-NP', 'O')
The CNV losses showed genome-wide significance for association with RBC on 3q22 (p=8.5×10−9).
('The', 'The', 'DT', 'B-NP', 'O')
('CNV', 'CNV', 'NN', 'I-NP', 'O')
('losses', 'loss', 'NNS', 'I-NP', 'O')
('showed', 'show', 'VBD', 'B-VP', 'O')
('genome-wide', 'genome-wide', 'JJ', 'B-NP', 'O')
('significance', 'significance', 'NN', 'I-NP', 'O')
('for', 'for', 'IN', 'B-PP', 'O')
('association', 'association', 'NN', 'B-NP', 'O')
('with', 'with', 'IN', 'B-PP', 'O')
('RBC', 'RBC', 'NN', 'B-NP', 'B-protein')
('on', 'on', 'IN', 'B-PP', 'O')
('3q22', '3q22', 'NN', 'B-NP', 'B-DNA')
('(p=8.5×10−9).', '(p=8.5×10−9).', '.', 'O', 'O')
The neighbor gene, COL6A5 (collagen alpha-5(VI) chain; collagen, type XXIX, alpha 1), has been linked to atopic dermatitis and is expressed in lymph, lung, ovary, brain, retina, bladder, and skin.
('The', 'The', 'DT', 'B-NP', 'O')
('neighbor', 'neighbor', 'NN', 'I-NP', 'O')
('gene,', 'gene,', 'NN', 'I-NP', 'O')
('COL6A5', 'COL6A5', 'NN', 'I-NP', 'O')
('(collagen', '(collagen', 'NN', 'I-NP', 'O')
('alpha-5(VI)', 'alpha-5(VI)', 'NN', 'I-NP', 'O')
('chain;', 'chain;', 'NN', 'I-NP', 'O')
('collagen,', 'collagen,', 'NN', 'I-NP', 'O')
('type', 'type', 'NN', 'I-NP', 'O')
('XXIX,', 'XXIX,', 'NN', 'I-NP', 'O')
('alpha', 'alpha', 'NN', 'I-NP', 'O')
('1),', '1),', 'NN', 'I-NP', 'O')
('has', 'have', 'VBZ', 'B-VP', 'O')
('been', 'be', 'VBN', 'I-VP', 'O')
('linked', 'link', 'VBN', 'I-VP', 'O')
('to', 'to', 'TO', 'B-PP', 'O')
('atopic', 'atopic', 'JJ', 'B-NP', 'O')
('dermatitis', 'dermatitis', 'NN', 'I-NP', 'O')
('and', 'and', 'CC', 'O', 'O')
('is', 'be', 'VBZ', 'B-VP', 'O')
('expressed', 'express', 'VBN', 'I-VP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('lymph,', 'lymph,', 'NN', 'B-NP', 'O')
('lung,', 'lung,', 'NN', 'I-NP', 'O')
('ovary,', 'ovary,', 'NN', 'I-NP', 'O')
('brain,', 'brain,', 'NN', 'I-NP', 'O')
('retina,', 'retina,', 'NN', 'I-NP', 'O')
('bladder,', 'bladder,', 'NN', 'I-NP', 'O')
('and', 'and', 'CC', 'O', 'O')
('skin.', 'skin.', 'NN', 'B-NP', 'O')
We observed a locus associated with Hb in CPNE4 on 3q22.1 (p=2.6×10−5).
('We', 'We', 'PRP', 'B-NP', 'O')
('observed', 'observe', 'VBD', 'B-VP', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('locus', 'locus', 'NN', 'I-NP', 'O')
('associated', 'associate', 'VBN', 'B-VP', 'O')
('with', 'with', 'IN', 'B-PP', 'O')
('Hb', 'Hb', 'NN', 'B-NP', 'B-protein')
('in', 'in', 'IN', 'B-PP', 'O')
('CPNE4', 'CPNE4', 'NN', 'B-NP', 'B-protein')
('on', 'on', 'IN', 'B-PP', 'O')
('3q22.1', '3q22.1', 'NN', 'B-NP', 'B-DNA')
('(p=2.6×10−5).', '(p=2.6×10−5).', '.', 'O', 'O')
CPNE4 is calciumdependent and regulates molecular events at the interface of the cell membrane and cytoplasm.
('CPNE4', 'CPNE4', 'NN', 'B-NP', 'B-protein')
('is', 'be', 'VBZ', 'B-VP', 'O')
('calciumdependent', 'calciumdependent', 'JJ', 'B-ADJP', 'O')
('and', 'and', 'CC', 'O', 'O')
('regulates', 'regulate', 'VBZ', 'B-VP', 'O')
('molecular', 'molecular', 'JJ', 'B-NP', 'O')
('events', 'event', 'NNS', 'I-NP', 'O')
('at', 'at', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('interface', 'interface', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('cell', 'cell', 'NN', 'I-NP', 'O')
('membrane', 'membrane', 'NN', 'I-NP', 'O')
('and', 'and', 'CC', 'O', 'O')
('cytoplasm.', 'cytoplasm.', 'NN', 'B-NP', 'O')
The most significant association with Hb was found in CPNE4 on 3q22.1 (p=8.3×10−5), and this gene encodes calcium-dependent membrane-binding proteins regulating molecular events at the interface of the cell membrane and cytoplasm.
('The', 'The', 'DT', 'B-NP', 'O')
('most', 'most', 'RBS', 'I-NP', 'O')
('significant', 'significant', 'JJ', 'I-NP', 'O')
('association', 'association', 'NN', 'I-NP', 'O')
('with', 'with', 'IN', 'B-PP', 'O')
('Hb', 'Hb', 'NN', 'B-NP', 'B-protein')
('was', 'be', 'VBD', 'B-VP', 'O')
('found', 'find', 'VBN', 'I-VP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('CPNE4', 'CPNE4', 'NN', 'B-NP', 'B-protein')
('on', 'on', 'IN', 'B-PP', 'O')
('3q22.1', '3q22.1', 'NN', 'B-NP', 'B-DNA')
('(p=8.3×10−5),', '(p=8.3×10−5),', 'NN', 'I-NP', 'I-DNA')
('and', 'and', 'CC', 'O', 'I-DNA')
('this', 'this', 'DT', 'B-NP', 'I-DNA')
('gene', 'gene', 'NN', 'I-NP', 'I-DNA')
('encodes', 'encode', 'VBZ', 'B-VP', 'O')
('calcium-dependent', 'calcium-dependent', 'JJ', 'B-NP', 'B-protein')
('membrane-binding', 'membrane-binding', 'JJ', 'I-NP', 'I-protein')
('proteins', 'protein', 'NNS', 'I-NP', 'I-protein')
('regulating', 'regulate', 'VBG', 'B-VP', 'O')
('molecular', 'molecular', 'JJ', 'B-NP', 'O')
('events', 'event', 'NNS', 'I-NP', 'O')
('at', 'at', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('interface', 'interface', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('cell', 'cell', 'NN', 'I-NP', 'O')
('membrane', 'membrane', 'NN', 'I-NP', 'O')
('and', 'and', 'CC', 'O', 'O')
('cytoplasm.', 'cytoplasm.', 'NN', 'B-NP', 'O')
We identified a Hct-associated loci on 6p21.2 (p= 8.1×10−5) and the nearest gene, hypothetical LOC401260 (FLJ41649), that had no functional importance.
('We', 'We', 'PRP', 'B-NP', 'O')
('identified', 'identify', 'VBD', 'B-VP', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('Hct-associated', 'Hct-associated', 'JJ', 'I-NP', 'B-DNA')
('loci', 'locus', 'NNS', 'I-NP', 'I-DNA')
('on', 'on', 'IN', 'B-PP', 'O')
('6p21.2', '6p21.2', 'CD', 'B-NP', 'O')
('(p=', '(p=', 'SYM', 'I-NP', 'O')
('8.1×10−5)', '8.1×10−5)', 'CD', 'I-NP', 'O')
('and', 'and', 'CC', 'O', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('nearest', 'near', 'JJS', 'I-NP', 'O')
('gene,', 'gene,', 'NN', 'I-NP', 'O')
('hypothetical', 'hypothetical', 'JJ', 'I-NP', 'O')
('LOC401260', 'LOC401260', 'NN', 'I-NP', 'O')
('(FLJ41649),', '(FLJ41649),', 'NN', 'I-NP', 'O')
('that', 'that', 'WDT', 'B-NP', 'O')
('had', 'have', 'VBD', 'B-VP', 'O')
('no', 'no', 'DT', 'B-NP', 'O')
('functional', 'functional', 'JJ', 'I-NP', 'O')
('importance.', 'importance.', 'NN', 'I-NP', 'O')
Variation_4715 reported by Wong et al.
('Variation_4715', 'Variation_4715', 'NN', 'B-NP', 'O')
('reported', 'report', 'VBN', 'B-VP', 'O')
('by', 'by', 'IN', 'B-PP', 'O')
('Wong', 'Wong', 'NNP', 'B-NP', 'O')
('et', 'et', 'FW', 'I-NP', 'O')
('al.', 'al.', 'FW', 'I-NP', 'O')
and Variation_29871 reported by Jakobsson et al.
('and', 'and', 'CC', 'O', 'O')
('Variation_29871', 'Variation_29871', 'NN', 'B-NP', 'O')
('reported', 'report', 'VBN', 'B-VP', 'O')
('by', 'by', 'IN', 'B-PP', 'O')
('Jakobsson', 'Jakobsson', 'NNP', 'B-NP', 'O')
('et', 'et', 'FW', 'I-NP', 'O')
('al.', 'al.', 'FW', 'I-NP', 'O')
are located in this region.
('are', 'be', 'VBP', 'B-VP', 'O')
('located', 'located', 'JJ', 'B-ADJP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('this', 'this', 'DT', 'B-NP', 'O')
('region.', 'region.', 'NN', 'I-NP', 'O')
Additional signals were collectively found in FAM53B, a family with sequence similarity 53, member B, on 10q26.13 (p=7.9×10−5), pregnancy specific beta1glycoprotein 11 (PSG11), and pregnancy specific beta-1-glycoprotein 6 (PSG6) on 19q13.31.
('Additional', 'Additional', 'JJ', 'B-NP', 'O')
('signals', 'signal', 'NNS', 'I-NP', 'O')
('were', 'be', 'VBD', 'B-VP', 'O')
('collectively', 'collectively', 'RB', 'I-VP', 'O')
('found', 'find', 'VBN', 'I-VP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('FAM53B,', 'FAM53B,', 'NN', 'B-NP', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('family', 'family', 'NN', 'I-NP', 'O')
('with', 'with', 'IN', 'B-PP', 'O')
('sequence', 'sequence', 'NN', 'B-NP', 'O')
('similarity', 'similarity', 'NN', 'I-NP', 'O')
('53,', '53,', 'CD', 'I-NP', 'O')
('member', 'member', 'NN', 'I-NP', 'O')
('B,', 'B,', 'NN', 'I-NP', 'O')
('on', 'on', 'IN', 'B-PP', 'O')
('10q26.13', '10q26.13', 'CD', 'B-NP', 'O')
('(p=7.9×10−5),', '(p=7.9×10−5),', 'NN', 'I-NP', 'O')
('pregnancy', 'pregnancy', 'NN', 'I-NP', 'O')
('specific', 'specific', 'JJ', 'I-NP', 'O')
('beta1glycoprotein', 'beta1glycoprotein', 'NN', 'I-NP', 'O')
('11', '11', 'CD', 'I-NP', 'O')
('(PSG11),', '(PSG11),', 'NN', 'I-NP', 'O')
('and', 'and', 'CC', 'I-NP', 'O')
('pregnancy', 'pregnancy', 'NN', 'I-NP', 'O')
('specific', 'specific', 'JJ', 'I-NP', 'O')
('beta-1-glycoprotein', 'beta-1-glycoprotein', 'NN', 'I-NP', 'O')
('6', '6', 'CD', 'I-NP', 'O')
('(PSG6)', '(PSG6)', 'NN', 'I-NP', 'B-protein')
('on', 'on', 'IN', 'B-PP', 'O')
('19q13.31.', '19q13.31.', 'CD', 'B-NP', 'O')
PSGs are mainly produced by the placental syncytiotrophoblasts during pregnancy and belong to the immunoglobulin superfamily.
('PSGs', 'PSG', 'NNS', 'B-NP', 'B-protein')
('are', 'be', 'VBP', 'B-VP', 'O')
('mainly', 'mainly', 'RB', 'I-VP', 'O')
('produced', 'produce', 'VBN', 'I-VP', 'O')
('by', 'by', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('placental', 'placental', 'JJ', 'I-NP', 'B-cell_type')
('syncytiotrophoblasts', 'syncytiotrophoblast', 'NNS', 'I-NP', 'I-cell_type')
('during', 'during', 'IN', 'B-PP', 'O')
('pregnancy', 'pregnancy', 'NN', 'B-NP', 'O')
('and', 'and', 'CC', 'O', 'O')
('belong', 'belong', 'VBP', 'B-VP', 'O')
('to', 'to', 'TO', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('immunoglobulin', 'immunoglobulin', 'NN', 'I-NP', 'O')
('superfamily.', 'superfamily.', 'NN', 'I-NP', 'O')
We identified CNV losses associated with MCHC on 6p21.2 (p=8.1×10−5).
('We', 'We', 'PRP', 'B-NP', 'O')
('identified', 'identify', 'VBD', 'B-VP', 'O')
('CNV', 'CNV', 'NN', 'B-NP', 'O')
('losses', 'loss', 'NNS', 'I-NP', 'O')
('associated', 'associate', 'VBN', 'B-VP', 'O')
('with', 'with', 'IN', 'B-PP', 'O')
('MCHC', 'MCHC', 'NN', 'B-NP', 'B-protein')
('on', 'on', 'IN', 'B-PP', 'O')
('6p21.2', '6p21.2', 'CD', 'B-NP', 'B-DNA')
('(p=8.1×10−5).', '(p=8.1×10−5).', 'LS', 'O', 'O')
The nearest gene, DEAH (Asp Glu-Ala-His) box polypeptide 9 pseudogene (AB231715), had no functional importance yet but Variation_3851 and Variation_2925 were reported by Redon et al.
('The', 'The', 'DT', 'B-NP', 'O')
('nearest', 'near', 'JJS', 'I-NP', 'O')
('gene,', 'gene,', 'NN', 'I-NP', 'O')
('DEAH', 'DEAH', 'NN', 'I-NP', 'O')
('(Asp', '(Asp', 'NN', 'I-NP', 'O')
('Glu-Ala-His)', 'Glu-Ala-His)', 'NN', 'I-NP', 'O')
('box', 'box', 'NN', 'I-NP', 'O')
('polypeptide', 'polypeptide', 'NN', 'I-NP', 'O')
('9', '9', 'CD', 'I-NP', 'O')
('pseudogene', 'pseudogene', 'NN', 'I-NP', 'O')
('(AB231715),', '(AB231715),', 'NN', 'I-NP', 'O')
('had', 'have', 'VBD', 'B-VP', 'O')
('no', 'no', 'DT', 'B-NP', 'O')
('functional', 'functional', 'JJ', 'I-NP', 'O')
('importance', 'importance', 'NN', 'I-NP', 'O')
('yet', 'yet', 'RB', 'B-ADVP', 'O')
('but', 'but', 'CC', 'O', 'O')
('Variation_3851', 'Variation_3851', 'NN', 'B-NP', 'O')
('and', 'and', 'CC', 'I-NP', 'O')
('Variation_2925', 'Variation_2925', 'NN', 'I-NP', 'O')
('were', 'be', 'VBD', 'B-VP', 'O')
('reported', 'report', 'VBN', 'I-VP', 'O')
('by', 'by', 'IN', 'B-PP', 'O')
('Redon', 'Redon', 'NNP', 'B-NP', 'O')
('et', 'et', 'FW', 'I-NP', 'O')
('al.', 'al.', 'FW', 'I-NP', 'O')
in the region.
('in', 'in', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('region.', 'region.', 'NN', 'I-NP', 'O')
The most significant association with PLT was found on 2p13.1 (p=5.0×10−6) and spanned many genes, such as DEAQ box RNA-dependent ATPase 1 (DQX1), ancient ubiquitous protein 1 (AUP1), HtrA serine peptidase 2 (HTRA2), and lysyl oxidase-like 3 (LOXL3).
('The', 'The', 'DT', 'B-NP', 'O')
('most', 'most', 'RBS', 'I-NP', 'O')
('significant', 'significant', 'JJ', 'I-NP', 'O')
('association', 'association', 'NN', 'I-NP', 'O')
('with', 'with', 'IN', 'B-PP', 'O')
('PLT', 'PLT', 'NN', 'B-NP', 'B-protein')
('was', 'be', 'VBD', 'B-VP', 'O')
('found', 'find', 'VBN', 'I-VP', 'O')
('on', 'on', 'IN', 'B-PP', 'O')
('2p13.1', '2p13.1', 'NN', 'B-NP', 'O')
('(p=5.0×10−6)', '(p=5.0×10−6)', 'NN', 'I-NP', 'O')
('and', 'and', 'CC', 'O', 'O')
('spanned', 'span', 'VBD', 'B-VP', 'O')
('many', 'many', 'JJ', 'B-NP', 'O')
('genes,', 'genes,', 'NN', 'I-NP', 'O')
('such', 'such', 'JJ', 'B-PP', 'O')
('as', 'as', 'IN', 'I-PP', 'O')
('DEAQ', 'DEAQ', 'NN', 'B-NP', 'B-DNA')
('box', 'box', 'NN', 'I-NP', 'I-DNA')
('RNA-dependent', 'RNA-dependent', 'JJ', 'I-NP', 'O')
('ATPase', 'ATPase', 'NN', 'I-NP', 'O')
('1', '1', 'CD', 'I-NP', 'O')
('(DQX1),', '(DQX1),', 'NN', 'I-NP', 'B-protein')
('ancient', 'ancient', 'JJ', 'I-NP', 'O')
('ubiquitous', 'ubiquitous', 'JJ', 'I-NP', 'O')
('protein', 'protein', 'NN', 'I-NP', 'O')
('1', '1', 'CD', 'I-NP', 'O')
('(AUP1),', '(AUP1),', 'NN', 'I-NP', 'O')
('HtrA', 'HtrA', 'NN', 'I-NP', 'O')
('serine', 'serine', 'NN', 'I-NP', 'O')
('peptidase', 'peptidase', 'NN', 'I-NP', 'O')
('2', '2', 'CD', 'I-NP', 'O')
('(HTRA2),', '(HTRA2),', 'NN', 'I-NP', 'B-protein')
('and', 'and', 'CC', 'O', 'O')
('lysyl', 'lysyl', 'NN', 'B-NP', 'O')
('oxidase-like', 'oxidase-like', 'JJ', 'B-NP', 'O')
('3', '3', 'CD', 'I-NP', 'O')
('(LOXL3).', '(LOXL3).', 'NN', 'I-NP', 'O')
Among those genes, AUP1 is involved in binding ubiquitinconjugating enzymes.
('Among', 'Among', 'IN', 'B-PP', 'O')
('those', 'those', 'DT', 'B-NP', 'O')
('genes,', 'genes,', 'NN', 'I-NP', 'O')
('AUP1', 'AUP1', 'NN', 'I-NP', 'O')
('is', 'be', 'VBZ', 'B-VP', 'O')
('involved', 'involve', 'VBN', 'I-VP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('binding', 'binding', 'NN', 'B-NP', 'O')
('ubiquitinconjugating', 'ubiquitinconjugate', 'VBG', 'B-VP', 'O')
('enzymes.', 'enzymes.', 'NNS', 'B-NP', 'O')
AUP1 also binds to the cytoplasmic tail of integrin alpha (IIb) subunits, which play a crucial role in the integrin alpha (IIb) beta (3) insideout signaling in platelets and megakaryocytes that leads to platelet aggregation and thrombus formation.
('AUP1', 'AUP1', 'NN', 'B-NP', 'B-protein')
('also', 'also', 'RB', 'B-ADVP', 'O')
('binds', 'bind', 'VBZ', 'B-VP', 'O')
('to', 'to', 'TO', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('cytoplasmic', 'cytoplasmic', 'JJ', 'I-NP', 'B-protein')
('tail', 'tail', 'NN', 'I-NP', 'I-protein')
('of', 'of', 'IN', 'B-PP', 'O')
('integrin', 'integrin', 'NN', 'B-NP', 'B-protein')
('alpha', 'alpha', 'NN', 'I-NP', 'I-protein')
('(IIb)', '(IIb)', 'NN', 'I-NP', 'I-protein')
('subunits,', 'subunits,', 'NN', 'I-NP', 'I-protein')
('which', 'which', 'WDT', 'B-NP', 'O')
('play', 'play', 'VBP', 'B-VP', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('crucial', 'crucial', 'JJ', 'I-NP', 'O')
('role', 'role', 'NN', 'I-NP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('integrin', 'integrin', 'NN', 'I-NP', 'B-protein')
('alpha', 'alpha', 'NN', 'I-NP', 'I-protein')
('(IIb)', '(IIb)', 'NN', 'I-NP', 'I-protein')
('beta', 'beta', 'SYM', 'B-VP', 'I-protein')
('(3)', '(3)', 'LS', 'B-LST', 'O')
('insideout', 'insideout', 'IN', 'B-PP', 'O')
('signaling', 'signaling', 'NN', 'B-NP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('platelets', 'platelet', 'NNS', 'B-NP', 'B-cell_type')
('and', 'and', 'CC', 'I-NP', 'O')
('megakaryocytes', 'megakaryocyte', 'NNS', 'I-NP', 'B-cell_type')
('that', 'that', 'WDT', 'B-NP', 'O')
('leads', 'lead', 'VBZ', 'B-VP', 'O')
('to', 'to', 'TO', 'I-VP', 'O')
('platelet', 'platelet', 'VB', 'I-VP', 'O')
('aggregation', 'aggregation', 'NN', 'B-NP', 'O')
('and', 'and', 'CC', 'I-NP', 'O')
('thrombus', 'thrombus', 'NN', 'I-NP', 'O')
('formation.', 'formation.', 'NN', 'I-NP', 'O')
HTRA2 encodes a serine protease that induces apoptosis.
('HTRA2', 'HTRA2', 'NN', 'B-NP', 'B-protein')
('encodes', 'encode', 'VBZ', 'B-VP', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('serine', 'serine', 'NN', 'I-NP', 'B-protein')
('protease', 'protease', 'NN', 'I-NP', 'I-protein')
('that', 'that', 'WDT', 'B-NP', 'O')
('induces', 'induce', 'VBZ', 'B-VP', 'O')
('apoptosis.', 'apoptosis.', 'NN', 'B-NP', 'O')
LOXL3 is essential to the biogenesis of connective tissue having roles in developmental regulation, senescence, tumor suppression, cell growth control, and chemotaxis to each member of the family.
('LOXL3', 'LOXL3', 'NN', 'B-NP', 'B-protein')
('is', 'be', 'VBZ', 'B-VP', 'O')
('essential', 'essential', 'JJ', 'B-ADJP', 'O')
('to', 'to', 'TO', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('biogenesis', 'biogenesis', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('connective', 'connective', 'JJ', 'B-NP', 'O')
('tissue', 'tissue', 'NN', 'I-NP', 'O')
('having', 'have', 'VBG', 'B-VP', 'O')
('roles', 'role', 'NNS', 'B-NP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('developmental', 'developmental', 'JJ', 'B-NP', 'O')
('regulation,', 'regulation,', 'NN', 'I-NP', 'O')
('senescence,', 'senescence,', 'NN', 'I-NP', 'O')
('tumor', 'tumor', 'NN', 'I-NP', 'O')
('suppression,', 'suppression,', 'NN', 'I-NP', 'O')
('cell', 'cell', 'NN', 'I-NP', 'O')
('growth', 'growth', 'NN', 'I-NP', 'O')
('control,', 'control,', 'NN', 'I-NP', 'O')
('and', 'and', 'CC', 'O', 'O')
('chemotaxis', 'chemotaxis', 'NN', 'B-NP', 'O')
('to', 'to', 'TO', 'B-PP', 'O')
('each', 'each', 'DT', 'B-NP', 'O')
('member', 'member', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('family.', 'family.', 'NN', 'I-NP', 'O')
Thousands of structural variants, consisting of 512% of the human genome, are not only revealing, but they are also expected in gene expression.
('Thousands', 'Thousand', 'NNS', 'B-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('structural', 'structural', 'JJ', 'B-NP', 'O')
('variants,', 'variants,', 'NN', 'I-NP', 'O')
('consisting', 'consist', 'VBG', 'B-VP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('512%', '512%', 'NN', 'B-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('human', 'human', 'JJ', 'I-NP', 'B-protein')
('genome,', 'genome,', 'NN', 'I-NP', 'I-protein')
('are', 'be', 'VBP', 'B-VP', 'O')
('not', 'not', 'RB', 'I-VP', 'O')
('only', 'only', 'RB', 'I-VP', 'O')
('revealing,', 'revealing,', 'VB', 'I-VP', 'O')
('but', 'but', 'CC', 'O', 'O')
('they', 'they', 'PRP', 'B-NP', 'O')
('are', 'be', 'VBP', 'B-VP', 'O')
('also', 'also', 'RB', 'I-VP', 'O')
('expected', 'expect', 'VBN', 'I-VP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('gene', 'gene', 'NN', 'B-NP', 'O')
('expression.', 'expression.', 'NN', 'I-NP', 'O')
CNVs representing structural variants are reported to be related to disease susceptibility.
('CNVs', 'CNV', 'NNS', 'B-NP', 'B-protein')
('representing', 'represent', 'VBG', 'B-VP', 'I-protein')
('structural', 'structural', 'JJ', 'B-NP', 'I-protein')
('variants', 'variant', 'NNS', 'I-NP', 'I-protein')
('are', 'be', 'VBP', 'B-VP', 'O')
('reported', 'report', 'VBN', 'I-VP', 'O')
('to', 'to', 'TO', 'I-VP', 'O')
('be', 'be', 'VB', 'I-VP', 'O')
('related', 'relate', 'VBN', 'I-VP', 'O')
('to', 'to', 'TO', 'B-PP', 'O')
('disease', 'disease', 'NN', 'B-NP', 'O')
('susceptibility.', 'susceptibility.', 'NN', 'I-NP', 'O')
The frequency of CNVs is different between populations, and more than 60% of detected CNV are known to be located outside of genes (Conrad et al., 2010).
('The', 'The', 'DT', 'B-NP', 'O')
('frequency', 'frequency', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('CNVs', 'CNV', 'NNS', 'B-NP', 'B-protein')
('is', 'be', 'VBZ', 'B-VP', 'O')
('different', 'different', 'JJ', 'B-ADJP', 'O')
('between', 'between', 'IN', 'B-PP', 'O')
('populations,', 'populations,', 'NN', 'B-NP', 'O')
('and', 'and', 'CC', 'O', 'O')
('more', 'more', 'JJR', 'B-ADJP', 'O')
('than', 'than', 'IN', 'B-PP', 'O')
('60%', '60%', 'NN', 'B-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('detected', 'detect', 'VBN', 'B-NP', 'O')
('CNV', 'CNV', 'NN', 'I-NP', 'O')
('are', 'be', 'VBP', 'B-VP', 'O')
('known', 'know', 'VBN', 'I-VP', 'O')
('to', 'to', 'TO', 'I-VP', 'O')
('be', 'be', 'VB', 'I-VP', 'O')
('located', 'locate', 'VBN', 'I-VP', 'O')
('outside', 'outside', 'IN', 'B-ADVP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('genes', 'gene', 'NNS', 'B-NP', 'O')
('(Conrad', '(Conrad', 'NNP', 'B-NP', 'O')
('et', 'et', 'NN', 'I-NP', 'O')
('al.,', 'al.,', 'IN', 'B-PP', 'O')
('2010).', '2010).', 'CD', 'B-NP', 'O')
Most common CNV (MAF＞5%) is well tagged on SNP arrays, and this suggests that a possible contribution of common CNVs to disease analyzing the disease association of CNVtagging SNPs (McCarroll et al., 2008).
('Most', 'Most', 'RBS', 'B-NP', 'O')
('common', 'common', 'JJ', 'I-NP', 'O')
('CNV', 'CNV', 'NN', 'I-NP', 'O')
('(MAF＞5%)', '(MAF＞5%)', 'NN', 'I-NP', 'O')
('is', 'be', 'VBZ', 'B-VP', 'O')
('well', 'well', 'RB', 'I-VP', 'O')
('tagged', 'tag', 'VBN', 'I-VP', 'O')
('on', 'on', 'IN', 'B-PP', 'O')
('SNP', 'SNP', 'NN', 'B-NP', 'O')
('arrays,', 'arrays,', 'NN', 'I-NP', 'O')
('and', 'and', 'CC', 'O', 'O')
('this', 'this', 'DT', 'B-NP', 'O')
('suggests', 'suggest', 'VBZ', 'B-VP', 'O')
('that', 'that', 'IN', 'B-SBAR', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('possible', 'possible', 'JJ', 'I-NP', 'O')
('contribution', 'contribution', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('common', 'common', 'JJ', 'B-NP', 'O')
('CNVs', 'CNV', 'NNS', 'I-NP', 'O')
('to', 'to', 'TO', 'B-PP', 'O')
('disease', 'disease', 'NN', 'B-NP', 'O')
('analyzing', 'analyze', 'VBG', 'B-VP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('disease', 'disease', 'NN', 'I-NP', 'O')
('association', 'association', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('CNVtagging', 'CNVtagging', 'NNP', 'B-NP', 'O')
('SNPs', 'SNPs', 'NNP', 'I-NP', 'O')
('(McCarroll', '(McCarroll', 'NNP', 'I-NP', 'O')
('et', 'et', 'NNP', 'I-NP', 'O')
('al.,', 'al.,', 'IN', 'B-PP', 'O')
('2008).', '2008).', 'CD', 'B-NP', 'O')
It is becoming increasingly clear that genetic studies of complex diseases and quantitative traits must pay closer attention to the contributions of CNVs.
('It', 'It', 'PRP', 'B-NP', 'O')
('is', 'be', 'VBZ', 'B-VP', 'O')
('becoming', 'become', 'VBG', 'I-VP', 'O')
('increasingly', 'increasingly', 'RB', 'B-ADJP', 'O')
('clear', 'clear', 'JJ', 'I-ADJP', 'O')
('that', 'that', 'IN', 'B-SBAR', 'O')
('genetic', 'genetic', 'JJ', 'B-NP', 'O')
('studies', 'study', 'NNS', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('complex', 'complex', 'JJ', 'B-NP', 'O')
('diseases', 'disease', 'NNS', 'I-NP', 'O')
('and', 'and', 'CC', 'O', 'O')
('quantitative', 'quantitative', 'JJ', 'B-NP', 'O')
('traits', 'trait', 'NNS', 'I-NP', 'O')
('must', 'must', 'MD', 'B-VP', 'O')
('pay', 'pay', 'VB', 'I-VP', 'O')
('closer', 'close', 'JJR', 'B-NP', 'O')
('attention', 'attention', 'NN', 'I-NP', 'O')
('to', 'to', 'TO', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('contributions', 'contribution', 'NNS', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('CNVs.', 'CNVs.', 'NN', 'B-NP', 'B-protein')
Recent developments in genomewide analysis have helped to identify various loci related to quantitative traits, and complex diseases, hemostasis, thrombosis, and cardiovascular disease have been studied broadly for their relationships to these traits (Ganesh et al., 2009).
('Recent', 'Recent', 'JJ', 'B-NP', 'O')
('developments', 'development', 'NNS', 'I-NP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('genomewide', 'genomewide', 'JJ', 'B-NP', 'O')
('analysis', 'analysis', 'NN', 'I-NP', 'O')
('have', 'have', 'VBP', 'B-VP', 'O')
('helped', 'help', 'VBN', 'I-VP', 'O')
('to', 'to', 'TO', 'I-VP', 'O')
('identify', 'identify', 'VB', 'I-VP', 'O')
('various', 'various', 'JJ', 'B-NP', 'O')
('loci', 'locus', 'NNS', 'I-NP', 'O')
('related', 'relate', 'VBN', 'B-VP', 'O')
('to', 'to', 'TO', 'B-PP', 'O')
('quantitative', 'quantitative', 'JJ', 'B-NP', 'O')
('traits,', 'traits,', 'NN', 'I-NP', 'O')
('and', 'and', 'CC', 'O', 'O')
('complex', 'complex', 'JJ', 'B-NP', 'O')
('diseases,', 'diseases,', 'NN', 'I-NP', 'O')
('hemostasis,', 'hemostasis,', 'NN', 'I-NP', 'O')
('thrombosis,', 'thrombosis,', 'NN', 'I-NP', 'O')
('and', 'and', 'CC', 'O', 'O')
('cardiovascular', 'cardiovascular', 'JJ', 'B-NP', 'O')
('disease', 'disease', 'NN', 'I-NP', 'O')
('have', 'have', 'VBP', 'B-VP', 'O')
('been', 'be', 'VBN', 'I-VP', 'O')
('studied', 'study', 'VBN', 'I-VP', 'O')
('broadly', 'broadly', 'RB', 'B-ADVP', 'O')
('for', 'for', 'IN', 'B-PP', 'O')
('their', 'their', 'PRP$', 'B-NP', 'O')
('relationships', 'relationship', 'NNS', 'I-NP', 'O')
('to', 'to', 'TO', 'B-PP', 'O')
('these', 'these', 'DT', 'B-NP', 'O')
('traits', 'trait', 'NNS', 'I-NP', 'O')
('(Ganesh', '(Ganesh', 'VBP', 'B-VP', 'O')
('et', 'et', 'NN', 'B-NP', 'O')
('al.,', 'al.,', 'IN', 'B-PP', 'O')
('2009).', '2009).', 'CD', 'B-NP', 'O')
In contrast to the welldeveloped resources available for SNP association studies, we are still in the early phases of incorporating structural genetic variation in genomewide association studies.
('In', 'In', 'IN', 'B-PP', 'O')
('contrast', 'contrast', 'NN', 'B-NP', 'O')
('to', 'to', 'TO', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('welldeveloped', 'welldeveloped', 'JJ', 'I-NP', 'O')
('resources', 'resource', 'NNS', 'I-NP', 'O')
('available', 'available', 'JJ', 'B-ADJP', 'O')
('for', 'for', 'IN', 'B-PP', 'O')
('SNP', 'SNP', 'NN', 'B-NP', 'O')
('association', 'association', 'NN', 'I-NP', 'O')
('studies,', 'studies,', 'NN', 'I-NP', 'O')
('we', 'we', 'PRP', 'B-NP', 'O')
('are', 'be', 'VBP', 'B-VP', 'O')
('still', 'still', 'RB', 'B-ADVP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('early', 'early', 'JJ', 'I-NP', 'O')
('phases', 'phase', 'NNS', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('incorporating', 'incorporate', 'VBG', 'B-VP', 'O')
('structural', 'structural', 'JJ', 'B-NP', 'O')
('genetic', 'genetic', 'JJ', 'I-NP', 'O')
('variation', 'variation', 'NN', 'I-NP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('genomewide', 'genomewide', 'JJ', 'B-NP', 'O')
('association', 'association', 'NN', 'I-NP', 'O')
('studies.', 'studies.', 'NN', 'I-NP', 'O')
There was no strong genomewide association of CNVs in 16,000 cases of eight common diseases and 3,000 shared controls in WTCCC consortium though common CNVs are well tagged by SNP (Craddock et al., 2010).
('There', 'There', 'EX', 'B-NP', 'O')
('was', 'be', 'VBD', 'B-VP', 'O')
('no', 'no', 'DT', 'B-NP', 'O')
('strong', 'strong', 'JJ', 'I-NP', 'O')
('genomewide', 'genomewide', 'JJ', 'I-NP', 'O')
('association', 'association', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('CNVs', 'CNV', 'NNS', 'B-NP', 'B-protein')
('in', 'in', 'IN', 'B-PP', 'O')
('16,000', '16,000', 'CD', 'B-NP', 'O')
('cases', 'case', 'NNS', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('eight', 'eight', 'CD', 'B-NP', 'O')
('common', 'common', 'JJ', 'I-NP', 'O')
('diseases', 'disease', 'NNS', 'I-NP', 'O')
('and', 'and', 'CC', 'O', 'O')
('3,000', '3,000', 'CD', 'B-NP', 'O')
('shared', 'share', 'VBN', 'I-NP', 'O')
('controls', 'control', 'NNS', 'I-NP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('WTCCC', 'WTCCC', 'NN', 'B-NP', 'O')
('consortium', 'consortium', 'NN', 'I-NP', 'O')
('though', 'though', 'IN', 'B-SBAR', 'O')
('common', 'common', 'JJ', 'B-NP', 'O')
('CNVs', 'CNV', 'NNS', 'I-NP', 'O')
('are', 'be', 'VBP', 'B-VP', 'O')
('well', 'well', 'RB', 'I-VP', 'O')
('tagged', 'tag', 'VBN', 'I-VP', 'O')
('by', 'by', 'IN', 'B-PP', 'O')
('SNP', 'SNP', 'NNP', 'B-NP', 'O')
('(Craddock', '(Craddock', 'NNP', 'I-NP', 'O')
('et', 'et', 'NNP', 'I-NP', 'O')
('al.,', 'al.,', 'IN', 'B-PP', 'O')
('2010).', '2010).', 'CD', 'B-NP', 'O')
In contrast to the welldeveloped resources available for SNP association studies, we are still in the early phases of incorporating structural genetic variation in genomewide association studies.
('In', 'In', 'IN', 'B-PP', 'O')
('contrast', 'contrast', 'NN', 'B-NP', 'O')
('to', 'to', 'TO', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('welldeveloped', 'welldeveloped', 'JJ', 'I-NP', 'O')
('resources', 'resource', 'NNS', 'I-NP', 'O')
('available', 'available', 'JJ', 'B-ADJP', 'O')
('for', 'for', 'IN', 'B-PP', 'O')
('SNP', 'SNP', 'NN', 'B-NP', 'O')
('association', 'association', 'NN', 'I-NP', 'O')
('studies,', 'studies,', 'NN', 'I-NP', 'O')
('we', 'we', 'PRP', 'B-NP', 'O')
('are', 'be', 'VBP', 'B-VP', 'O')
('still', 'still', 'RB', 'B-ADVP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('early', 'early', 'JJ', 'I-NP', 'O')
('phases', 'phase', 'NNS', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('incorporating', 'incorporate', 'VBG', 'B-VP', 'O')
('structural', 'structural', 'JJ', 'B-NP', 'O')
('genetic', 'genetic', 'JJ', 'I-NP', 'O')
('variation', 'variation', 'NN', 'I-NP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('genomewide', 'genomewide', 'JJ', 'B-NP', 'O')
('association', 'association', 'NN', 'I-NP', 'O')
('studies.', 'studies.', 'NN', 'I-NP', 'O')
There was no strong genomewide association of CNVs in 16,000 cases of eight common diseases, and 3,000 shared controls in the WTCCC consortium though common CNVs are well tagged according to SNP (Ganesh et al., 2009; Soranzo et al., 2009).
('There', 'There', 'EX', 'B-NP', 'O')
('was', 'be', 'VBD', 'B-VP', 'O')
('no', 'no', 'DT', 'B-NP', 'O')
('strong', 'strong', 'JJ', 'I-NP', 'O')
('genomewide', 'genomewide', 'JJ', 'I-NP', 'O')
('association', 'association', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('CNVs', 'CNV', 'NNS', 'B-NP', 'B-protein')
('in', 'in', 'IN', 'B-PP', 'O')
('16,000', '16,000', 'CD', 'B-NP', 'O')
('cases', 'case', 'NNS', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('eight', 'eight', 'CD', 'B-NP', 'O')
('common', 'common', 'JJ', 'I-NP', 'O')
('diseases,', 'diseases,', 'NN', 'I-NP', 'O')
('and', 'and', 'CC', 'O', 'O')
('3,000', '3,000', 'CD', 'B-NP', 'O')
('shared', 'share', 'VBN', 'I-NP', 'O')
('controls', 'control', 'NNS', 'I-NP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('WTCCC', 'WTCCC', 'NN', 'I-NP', 'O')
('consortium', 'consortium', 'NN', 'I-NP', 'O')
('though', 'though', 'IN', 'B-SBAR', 'O')
('common', 'common', 'JJ', 'B-NP', 'O')
('CNVs', 'CNV', 'NNS', 'I-NP', 'O')
('are', 'be', 'VBP', 'B-VP', 'O')
('well', 'well', 'RB', 'I-VP', 'O')
('tagged', 'tag', 'VBN', 'I-VP', 'O')
('according', 'accord', 'VBG', 'B-PP', 'O')
('to', 'to', 'TO', 'B-PP', 'O')
('SNP', 'SNP', 'NNP', 'B-NP', 'O')
('(Ganesh', '(Ganesh', 'NNP', 'I-NP', 'O')
('et', 'et', 'NNP', 'I-NP', 'O')
('al.,', 'al.,', 'VBD', 'B-VP', 'O')
('2009;', '2009;', ':', 'O', 'O')
('Soranzo', 'Soranzo', 'NNP', 'B-NP', 'O')
('et', 'et', 'NNP', 'I-NP', 'O')
('al.,', 'al.,', 'IN', 'B-PP', 'O')
('2009).', '2009).', 'CD', 'B-NP', 'O')
The associations of these hematological traits in the Japanese were replicated in many of the loci, in addition to some novel loci.
('The', 'The', 'DT', 'B-NP', 'O')
('associations', 'association', 'NNS', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('these', 'these', 'DT', 'B-NP', 'O')
('hematological', 'hematological', 'JJ', 'I-NP', 'B-cell_type')
('traits', 'trait', 'NNS', 'I-NP', 'I-cell_type')
('in', 'in', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('Japanese', 'Japanese', 'NNS', 'I-NP', 'O')
('were', 'be', 'VBD', 'B-VP', 'O')
('replicated', 'replicate', 'VBN', 'I-VP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('many', 'many', 'JJ', 'B-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('loci,', 'loci,', 'NN', 'I-NP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('addition', 'addition', 'NN', 'B-NP', 'O')
('to', 'to', 'TO', 'B-PP', 'O')
('some', 'some', 'DT', 'B-NP', 'O')
('novel', 'novel', 'JJ', 'I-NP', 'O')
('loci.', 'loci.', 'NN', 'I-NP', 'O')
Most of the known loci associated with the   hematological traits in other populations were replicated in a Korean in our previous study (data not shown).
('Most', 'Most', 'JJS', 'B-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('known', 'known', 'JJ', 'I-NP', 'O')
('loci', 'locus', 'NNS', 'I-NP', 'O')
('associated', 'associate', 'VBN', 'B-VP', 'O')
('with', 'with', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('hematological', 'hematological', 'JJ', 'I-NP', 'O')
('traits', 'trait', 'NNS', 'I-NP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('other', 'other', 'JJ', 'B-NP', 'O')
('populations', 'population', 'NNS', 'I-NP', 'O')
('were', 'be', 'VBD', 'B-VP', 'O')
('replicated', 'replicate', 'VBN', 'I-VP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('Korean', 'Korean', 'NNP', 'I-NP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('our', 'our', 'PRP$', 'B-NP', 'O')
('previous', 'previous', 'JJ', 'I-NP', 'O')
('study', 'study', 'NN', 'I-NP', 'O')
('(data', '(data', 'NNS', 'I-NP', 'O')
('not', 'not', 'RB', 'O', 'O')
('shown).', 'shown).', 'VB', 'B-VP', 'O')
In this study, we report several CNV loci associated with hematological traits.
('In', 'In', 'IN', 'B-PP', 'O')
('this', 'this', 'DT', 'B-NP', 'O')
('study,', 'study,', 'NN', 'I-NP', 'O')
('we', 'we', 'PRP', 'B-NP', 'O')
('report', 'report', 'VBP', 'B-VP', 'O')
('several', 'several', 'JJ', 'B-NP', 'O')
('CNV', 'CNV', 'NN', 'I-NP', 'B-DNA')
('loci', 'locus', 'NNS', 'I-NP', 'I-DNA')
('associated', 'associate', 'VBN', 'B-VP', 'O')
('with', 'with', 'IN', 'B-PP', 'O')
('hematological', 'hematological', 'JJ', 'B-NP', 'O')
('traits.', 'traits.', 'NNS', 'I-NP', 'O')
We found genomewide significant associations with RBC and MCHC, and other hematological traits showed several peak signals.
('We', 'We', 'PRP', 'B-NP', 'O')
('found', 'find', 'VBD', 'B-VP', 'O')
('genomewide', 'genomewide', 'JJ', 'B-NP', 'O')
('significant', 'significant', 'JJ', 'I-NP', 'O')
('associations', 'association', 'NNS', 'I-NP', 'O')
('with', 'with', 'IN', 'B-PP', 'O')
('RBC', 'RBC', 'NN', 'B-NP', 'B-protein')
('and', 'and', 'CC', 'I-NP', 'O')
('MCHC,', 'MCHC,', 'NN', 'I-NP', 'B-protein')
('and', 'and', 'CC', 'O', 'O')
('other', 'other', 'JJ', 'B-NP', 'O')
('hematological', 'hematological', 'JJ', 'I-NP', 'O')
('traits', 'trait', 'NNS', 'I-NP', 'O')
('showed', 'show', 'VBD', 'B-VP', 'O')
('several', 'several', 'JJ', 'B-NP', 'O')
('peak', 'peak', 'JJ', 'I-NP', 'O')
('signals.', 'signals.', 'NN', 'I-NP', 'O')
CNV gains on 8p11.11 (p=1.8×10−10∼5.5×10−8) for association with RBC and CNV losses for association with RBC on 3q22 (p=8.5×10−9) showed genomewide significance, although the neighbor genes were not functionally related to hematological traits.
('CNV', 'CNV', 'NN', 'B-NP', 'B-protein')
('gains', 'gain', 'NNS', 'I-NP', 'I-protein')
('on', 'on', 'IN', 'B-PP', 'O')
('8p11.11', '8p11.11', 'CD', 'B-NP', 'O')
('(p=1.8×10−10∼5.5×10−8)', '(p=1.8×10−10∼5.5×10−8)', 'NN', 'I-NP', 'O')
('for', 'for', 'IN', 'B-PP', 'O')
('association', 'association', 'NN', 'B-NP', 'O')
('with', 'with', 'IN', 'B-PP', 'O')
('RBC', 'RBC', 'NN', 'B-NP', 'B-protein')
('and', 'and', 'CC', 'I-NP', 'O')
('CNV', 'CNV', 'NN', 'I-NP', 'O')
('losses', 'loss', 'NNS', 'I-NP', 'O')
('for', 'for', 'IN', 'B-PP', 'O')
('association', 'association', 'NN', 'B-NP', 'O')
('with', 'with', 'IN', 'B-PP', 'O')
('RBC', 'RBC', 'NN', 'B-NP', 'B-protein')
('on', 'on', 'IN', 'B-PP', 'O')
('3q22', '3q22', 'NN', 'B-NP', 'B-DNA')
('(p=8.5×10−9)', '(p=8.5×10−9)', 'NN', 'I-NP', 'O')
('showed', 'show', 'VBD', 'B-VP', 'O')
('genomewide', 'genomewide', 'JJ', 'B-NP', 'O')
('significance,', 'significance,', 'NN', 'I-NP', 'O')
('although', 'although', 'IN', 'B-SBAR', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('neighbor', 'neighbor', 'NN', 'I-NP', 'B-DNA')
('genes', 'gene', 'NNS', 'I-NP', 'I-DNA')
('were', 'be', 'VBD', 'B-VP', 'O')
('not', 'not', 'RB', 'I-VP', 'O')
('functionally', 'functionally', 'RB', 'I-VP', 'O')
('related', 'relate', 'VBN', 'I-VP', 'O')
('to', 'to', 'TO', 'B-PP', 'O')
('hematological', 'hematological', 'JJ', 'B-NP', 'B-cell_type')
('traits.', 'traits.', 'NNS', 'I-NP', 'I-cell_type')
We observed WBC-associated loci in NEB on 2q22 (p=5.2×10−7), which impacts the function of the cytoskeletal matrix, and 2p13.1 (p=5.0×10−6), which includes DQX1, AUP1, HTRA2 and LOXL3.
('We', 'We', 'PRP', 'B-NP', 'O')
('observed', 'observe', 'VBD', 'B-VP', 'O')
('WBC-associated', 'WBC-associated', 'JJ', 'B-NP', 'B-DNA')
('loci', 'locus', 'NNS', 'I-NP', 'I-DNA')
('in', 'in', 'IN', 'B-PP', 'O')
('NEB', 'NEB', 'NN', 'B-NP', 'B-protein')
('on', 'on', 'IN', 'B-PP', 'O')
('2q22', '2q22', 'NN', 'B-NP', 'B-DNA')
('(p=5.2×10−7),', '(p=5.2×10−7),', 'NN', 'I-NP', 'O')
('which', 'which', 'WDT', 'B-NP', 'O')
('impacts', 'impact', 'VBZ', 'B-VP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('function', 'function', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('cytoskeletal', 'cytoskeletal', 'JJ', 'I-NP', 'O')
('matrix,', 'matrix,', 'NN', 'I-NP', 'O')
('and', 'and', 'CC', 'I-NP', 'O')
('2p13.1', '2p13.1', 'NN', 'I-NP', 'O')
('(p=5.0×10−6),', '(p=5.0×10−6),', 'NN', 'I-NP', 'O')
('which', 'which', 'WDT', 'B-NP', 'O')
('includes', 'include', 'VBZ', 'B-VP', 'O')
('DQX1,', 'DQX1,', 'NN', 'B-NP', 'B-protein')
('AUP1,', 'AUP1,', 'NN', 'I-NP', 'O')
('HTRA2', 'HTRA2', 'NN', 'I-NP', 'O')
('and', 'and', 'CC', 'O', 'O')
('LOXL3.', 'LOXL3.', 'NN', 'B-NP', 'B-protein')
AUP1 plays a crucial role in the signaling of platelets and megakaryocytes, leading to platelet aggregation and thrombus formation.
('AUP1', 'AUP1', 'NN', 'B-NP', 'B-protein')
('plays', 'play', 'VBZ', 'B-VP', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('crucial', 'crucial', 'JJ', 'I-NP', 'O')
('role', 'role', 'NN', 'I-NP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('signaling', 'signaling', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('platelets', 'platelet', 'NNS', 'B-NP', 'B-cell_type')
('and', 'and', 'CC', 'O', 'O')
('megakaryocytes,', 'megakaryocytes,', 'NN', 'B-NP', 'O')
('leading', 'lead', 'VBG', 'B-VP', 'O')
('to', 'to', 'TO', 'I-VP', 'O')
('platelet', 'platelet', 'VB', 'I-VP', 'O')
('aggregation', 'aggregation', 'NN', 'B-NP', 'O')
('and', 'and', 'CC', 'I-NP', 'O')
('thrombus', 'thrombus', 'NN', 'I-NP', 'O')
('formation.', 'formation.', 'NN', 'I-NP', 'O')
HTRA2 is related to apoptosis, and LOXL3 is essential to the biogenesis of connective tissue, although no relation with a hematological trait was reported.
('HTRA2', 'HTRA2', 'NN', 'B-NP', 'B-protein')
('is', 'be', 'VBZ', 'B-VP', 'O')
('related', 'relate', 'VBN', 'I-VP', 'O')
('to', 'to', 'TO', 'B-PP', 'O')
('apoptosis,', 'apoptosis,', 'NN', 'B-NP', 'O')
('and', 'and', 'CC', 'I-NP', 'O')
('LOXL3', 'LOXL3', 'NN', 'I-NP', 'B-protein')
('is', 'be', 'VBZ', 'B-VP', 'O')
('essential', 'essential', 'JJ', 'B-ADJP', 'O')
('to', 'to', 'TO', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('biogenesis', 'biogenesis', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('connective', 'connective', 'JJ', 'B-NP', 'O')
('tissue,', 'tissue,', 'NN', 'I-NP', 'O')
('although', 'although', 'IN', 'B-SBAR', 'O')
('no', 'no', 'DT', 'B-NP', 'O')
('relation', 'relation', 'NN', 'I-NP', 'O')
('with', 'with', 'IN', 'B-PP', 'O')
('a', 'a', 'DT', 'B-NP', 'O')
('hematological', 'hematological', 'JJ', 'I-NP', 'O')
('trait', 'trait', 'NN', 'I-NP', 'O')
('was', 'be', 'VBD', 'B-VP', 'O')
('reported.', 'reported.', 'VBN', 'I-VP', 'O')
We also found loci associated with Hb on 3q22.1 (p=2.6×10−5), with Hct on 6p21.2 (p=8.1×10−5) and with MCHC on 6p21.2 (p=8.1×10−5).
('We', 'We', 'PRP', 'B-NP', 'O')
('also', 'also', 'RB', 'B-ADVP', 'O')
('found', 'find', 'VBD', 'B-VP', 'O')
('loci', 'locus', 'NNS', 'B-NP', 'O')
('associated', 'associate', 'VBN', 'B-VP', 'O')
('with', 'with', 'IN', 'B-PP', 'O')
('Hb', 'Hb', 'NN', 'B-NP', 'B-protein')
('on', 'on', 'IN', 'B-PP', 'O')
('3q22.1', '3q22.1', 'NN', 'B-NP', 'B-DNA')
('(p=2.6×10−5),', '(p=2.6×10−5),', 'NN', 'I-NP', 'I-DNA')
('with', 'with', 'IN', 'B-PP', 'O')
('Hct', 'Hct', 'NN', 'B-NP', 'B-protein')
('on', 'on', 'IN', 'B-PP', 'O')
('6p21.2', '6p21.2', 'CD', 'B-NP', 'B-DNA')
('(p=8.1×10−5)', '(p=8.1×10−5)', 'LS', 'B-PP', 'O')
('and', 'and', 'CC', 'I-PP', 'O')
('with', 'with', 'IN', 'B-PP', 'O')
('MCHC', 'MCHC', 'NN', 'B-NP', 'B-protein')
('on', 'on', 'IN', 'B-PP', 'O')
('6p21.2', '6p21.2', 'CD', 'B-NP', 'B-DNA')
('(p=8.1×10−5).', '(p=8.1×10−5).', 'LS', 'O', 'O')
CPNE4 on 3q22.1 impacts the interaction between the cell membrane and the cytoplasm.
('CPNE4', 'CPNE4', 'NN', 'B-NP', 'B-protein')
('on', 'on', 'IN', 'B-PP', 'O')
('3q22.1', '3q22.1', 'NN', 'B-NP', 'B-DNA')
('impacts', 'impact', 'VBZ', 'B-VP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('interaction', 'interaction', 'NN', 'I-NP', 'O')
('between', 'between', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('cell', 'cell', 'NN', 'I-NP', 'O')
('membrane', 'membrane', 'NN', 'I-NP', 'O')
('and', 'and', 'CC', 'O', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('cytoplasm.', 'cytoplasm.', 'NN', 'I-NP', 'O')
No other neighbor genes have this function.
('No', 'No', 'DT', 'B-NP', 'O')
('other', 'other', 'JJ', 'I-NP', 'O')
('neighbor', 'neighbor', 'NN', 'I-NP', 'B-DNA')
('genes', 'gene', 'NNS', 'I-NP', 'I-DNA')
('have', 'have', 'VBP', 'B-VP', 'O')
('this', 'this', 'DT', 'B-NP', 'O')
('function.', 'function.', 'NN', 'I-NP', 'O')
Previously reported Hct- and MCHC-associated CNV loci were detected, but no functional importance has been assigned to any of these loci (Iafrate et al., 2004).
('Previously', 'Previously', 'RB', 'B-NP', 'O')
('reported', 'report', 'VBN', 'I-NP', 'O')
('Hct-', 'Hct-', 'NN', 'I-NP', 'O')
('and', 'and', 'CC', 'I-NP', 'O')
('MCHC-associated', 'MCHC-associated', 'JJ', 'I-NP', 'B-protein')
('CNV', 'CNV', 'NN', 'I-NP', 'I-protein')
('loci', 'locus', 'NNS', 'I-NP', 'I-protein')
('were', 'be', 'VBD', 'B-VP', 'O')
('detected,', 'detected,', 'NN', 'B-NP', 'O')
('but', 'but', 'CC', 'O', 'O')
('no', 'no', 'DT', 'B-NP', 'O')
('functional', 'functional', 'JJ', 'I-NP', 'O')
('importance', 'importance', 'NN', 'I-NP', 'O')
('has', 'have', 'VBZ', 'B-VP', 'O')
('been', 'be', 'VBN', 'I-VP', 'O')
('assigned', 'assign', 'VBN', 'I-VP', 'O')
('to', 'to', 'TO', 'B-PP', 'O')
('any', 'any', 'DT', 'B-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('these', 'these', 'DT', 'B-NP', 'O')
('loci', 'locus', 'NNS', 'I-NP', 'O')
('(Iafrate', '(Iafrate', 'VBP', 'B-VP', 'O')
('et', 'et', 'NN', 'B-NP', 'O')
('al.,', 'al.,', 'IN', 'B-PP', 'O')
('2004).', '2004).', 'CD', 'B-NP', 'O')
In the future, curate-associated loci should be identified using various algorithms, since CNV detection is algorithm-dependent.
('In', 'In', 'IN', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('future,', 'future,', 'NN', 'I-NP', 'B-DNA')
('curate-associated', 'curate-associated', 'JJ', 'I-NP', 'I-DNA')
('loci', 'locus', 'NNS', 'I-NP', 'I-DNA')
('should', 'should', 'MD', 'B-VP', 'O')
('be', 'be', 'VB', 'I-VP', 'O')
('identified', 'identify', 'VBN', 'I-VP', 'O')
('using', 'use', 'VBG', 'B-VP', 'O')
('various', 'various', 'JJ', 'B-NP', 'O')
('algorithms,', 'algorithms,', 'NN', 'I-NP', 'O')
('since', 'since', 'IN', 'B-PP', 'O')
('CNV', 'CNV', 'NN', 'B-NP', 'O')
('detection', 'detection', 'NN', 'I-NP', 'O')
('is', 'be', 'VBZ', 'B-VP', 'O')
('algorithm-dependent.', 'algorithm-dependent.', 'JJ', 'B-ADJP', 'O')
Furthermore, in silico results should be verified using quantitative PCR (qPCR) and functional analysis.
('Furthermore,', 'Furthermore,', 'NN', 'B-NP', 'O')
('in', 'in', 'IN', 'B-PP', 'O')
('silico', 'silico', 'NN', 'B-NP', 'O')
('results', 'result', 'NNS', 'I-NP', 'O')
('should', 'should', 'MD', 'B-VP', 'O')
('be', 'be', 'VB', 'I-VP', 'O')
('verified', 'verify', 'VBN', 'I-VP', 'O')
('using', 'use', 'VBG', 'B-VP', 'O')
('quantitative', 'quantitative', 'JJ', 'B-NP', 'O')
('PCR', 'PCR', 'NN', 'I-NP', 'O')
('(qPCR)', '(qPCR)', 'NN', 'I-NP', 'O')
('and', 'and', 'CC', 'O', 'O')
('functional', 'functional', 'JJ', 'B-NP', 'O')
('analysis.', 'analysis.', 'NNS', 'I-NP', 'O')
To the best of our knowledge, this is the first genome-wide association study of CNV with hematological traits.
('To', 'To', 'TO', 'B-PP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('best', 'good', 'JJS', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('our', 'our', 'PRP$', 'B-NP', 'O')
('knowledge,', 'knowledge,', 'NN', 'I-NP', 'O')
('this', 'this', 'DT', 'B-NP', 'O')
('is', 'be', 'VBZ', 'B-VP', 'O')
('the', 'the', 'DT', 'B-NP', 'O')
('first', 'first', 'JJ', 'I-NP', 'O')
('genome-wide', 'genome-wide', 'JJ', 'I-NP', 'O')
('association', 'association', 'NN', 'I-NP', 'O')
('study', 'study', 'NN', 'I-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('CNV', 'CNV', 'NN', 'B-NP', 'B-protein')
('with', 'with', 'IN', 'B-PP', 'O')
('hematological', 'hematological', 'JJ', 'B-NP', 'O')
('traits.', 'traits.', 'NNS', 'I-NP', 'O')
In conclusion, our study offers understanding of hematological disease susceptibility as well as personalized prediction and prevention through combined SNP and CNV GWAS.
('In', 'In', 'IN', 'B-PP', 'O')
('conclusion,', 'conclusion,', 'NN', 'B-NP', 'O')
('our', 'our', 'PRP$', 'B-NP', 'O')
('study', 'study', 'NN', 'I-NP', 'O')
('offers', 'offer', 'VBZ', 'B-VP', 'O')
('understanding', 'understanding', 'NN', 'B-NP', 'O')
('of', 'of', 'IN', 'B-PP', 'O')
('hematological', 'hematological', 'JJ', 'B-NP', 'O')
('disease', 'disease', 'NN', 'I-NP', 'O')
('susceptibility', 'susceptibility', 'NN', 'I-NP', 'O')
('as', 'as', 'RB', 'B-CONJP', 'O')
('well', 'well', 'RB', 'I-CONJP', 'O')
('as', 'as', 'IN', 'I-CONJP', 'O')
('personalized', 'personalize', 'VBN', 'B-NP', 'O')
('prediction', 'prediction', 'NN', 'I-NP', 'O')
('and', 'and', 'CC', 'I-NP', 'O')
('prevention', 'prevention', 'NN', 'I-NP', 'O')
('through', 'through', 'IN', 'B-PP', 'O')
('combined', 'combine', 'VBN', 'B-NP', 'O')
('SNP', 'SNP', 'NNP', 'I-NP', 'O')
('and', 'and', 'CC', 'O', 'O')
('CNV', 'CNV', 'NNP', 'B-NP', 'O')
('GWAS.', 'GWAS.', 'NNP', 'I-NP', 'O')
